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Since the beginning of surgery, doctors have been using tiny needles and thread 
to construct vascular anastomosis, which is now considered as a gold standard for 
vascular anastomosis. However, the entire procedure of using needle and thread for 
vascular anastomosis is very complex and time consuming. Doctors need a long term 
practice to acquire this suturing skill and the outcome of the anastomosis largely 
depends on the individual surgical dexterity. Therefore, the surgeons need an 
alternative technique to construct revascularization in order to reduce the technical 
demand and individual surgical dexterity and expedite the anastomosis procedure. 
The aim of this study is to come up with a concept of a new anastomotic device 
to help the surgeon to speed up the anastomotic procedure and to make the procedure 
easy without compromising the quality of anastomosis. The proposed new device 
consists of an absorbable extraluminal ring with interlocking mechanism and to 
facilitate the attachment of the vessel with the ring, it utilizes the Bio-Glue. Poly L-
Lactic Acid (PLLA) a biocompatible and biodegradable polymer is chosen as the ring 
material. The ring is fabricated by casting virgin PLLA (pellet form) into a cylindrical 
rod, followed by conventional machining. It is expected that the entire anastomosis 
procedure can be completed within 10 min using this device whereas it takes about 20 
min using the standard suturing technique.  
Since PLLA is highly sensitive to processing technique and temperature, the 
mechanical strength (tensile and compressive) of the molded PLLA is investigated. 
Moreover, the degradation kinetics (weight loss) and the change of these mechanical 
properties of this material for up to eight weeks are also investigated. The study shows 






40MPa and 1.27GPa, compressive strength (σC) and modulus of compression (EC) is 
95MPa and 1.29GPa respectively. The results also show that within these eight weeks, 
PLLA exhibited a massive loss in tensile strength (σT) from 40MPa to 8MPa (about 
80%) and also in compressive strength (σC) from 95MPa to 24MPa (about 75%). But it 
does not show any significant weight loss within this time; which indicates that the 
degradation rate is much slower than needed and hence, the ring material should be 
reconsidered. 
This report describes the concept of this new anastomosis technique or device, 
the fabrication technique of this device and the physical and mechanical properties of 
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According to Encarta dictionary, the term “anastomosis” usually refers to the 
connection or the place of connection of two or more parts of natural branching system 
e.g. of blood vessels, leaf veins, stems of woody plants or rivers. In medical science, it 
refers to the surgical union of separated or severed tubular (hollow) organs (e.g. blood 
vessels or parts of the intestine) to ensure the continuity of the passageway. As for 
example, when a segment of intestine is resected, the two remaining ends are joined 
together and the procedure is referred to as an intestinal anastomosis. Micro-vascular 
surgery arbitrarily refers to the surgical procedures on arteries or veins below 2.5 mm 
outer diameter. Therefore, micro-vascular anastomosis means the joining of the blood 
vessel (arteries or veins) at microsurgical level. 
Basically, the joining method for blood vessel can be widely classified into two 
following divisions.  
 Suturing technique (Conventional Technique): The suture (thread) 
maintains the wound tissues (or hold the blood vessels together) in order to 
stop bleeding; until the natural healing process has provided a sufficient 
level of wound strength. 
 Sutureless technique: Any vascular reconstruction obtained without using 
hand sewing or hand tying knots can be classified as mechanical or 
sutureless anastomosis. With the advancement of technology so far several 




sutureless techniques have been developed for vascular reconstruction e.g. 
coupling device, staple, laser welding, bio glue, etc.  
With all these techniques, a faster and less traumatic anastomosis can be made 
as compared to suture techniques. However, each system is associated with its 
technique-related complications. As a consequence, the suture technique has been well 
established and widely accepted to the doctor as well as patient all over the world, and 
currently it is considered as a ‘gold’ standard in the field of vascular surgery. 
 
1.2 Significance of this study 
 
Since the beginning of surgery, surgeons have been using tiny needles and 
thread to accomplish microvascular anastomosis. The comfort to surgeons in 
performing a reliable anastomosis with the suture technique and the excellence of its 
long term results has led to its adoption as the gold standard. However, the surgical 
environment is becoming increasingly challenging for the surgeon since the advent of 
off pump bypass and minimally invasive approaches. One of the main drawbacks of 
the suture technique is it is a very complex and time-consuming process. Doctors need 
extensive training as well as a long time practice to acquire this suturing skill. The key 
element in performing a precise anastomosis is the placement of the sutures between 
vessels. Any imprecision may lead to anastomosis occlusion or severe flow 
impairment. Even unequal inter suture distance may result in the turbulence of blood 
flow, distortion of the vessel or excessive bleeding with platelet thrombus formation. 
That means surgical dexterity is still a determinant factor for anastomosis outcome.  
Moreover, the presence of the suture material inside the lumen may cause a 
foreign body reaction that in turn also increases the risk of intravascular thrombosis. 
Sometimes luminal narrowing by suture may also cause adverse eddy effects in the 




blood flow. Back walls may be inadvertently caught by the suture, causing immediate 
occlusion. Another problem is vessel trauma that is caused by the needle and thread 
while passing through the vessel. Moreover, sometimes the surgeon needs an extra 
number of sutures to make the anastomosis leak-proof and this further increases vessel 
trauma.  
Besides these, time is an important factor too; since flaps and digital tissue are 
unable to tolerate long ischemic times. The hand-sew anastomosis still requires the 
aortic cross clamp or side clamp with the risk of cerebral complications.  Usually it 
takes about 20 to 25 min to complete one vascular anastomosis by standard suturing 
technique. Due to the lengthiness of such procedures, surgeon fatigue may also result 
in sub-optimal results. In addition, long term use of surgical microscope may also 
cause fatigue. In certain situations, sutures would have to be inserted at an awkward 
angle, due to confined anatomic locations, thus further increasing the stress on the 
surgeon.  
Therefore, surgeons need an alternative way to construct revascularization in 
order to reduce the technical demand, standardize the quality of the surgical procedure, 
reduce the individual surgical dexterity as the determinant factor for the anastomosis 
outcome and expedite the procedure.  
However, the scope of this study can be briefly summarized as follows: 
 To design and develop a new anastomosis technique or device that would 
make the anastomosis procedure easy and would help the surgeon to speed up 
the procedure. 
 To find a suitable material for that device and fabricate that device with the 
proposed material. 




 To evaluate the proposed material as an anastomosis device in an in-vitro 
condition. 
 
1.3 Thesis organization 
 
The present chapter describes the background and the scope of this study. A 
brief summary of relevant literature pertaining to previous and most recently 
developed anastomosis techniques or devices is discussed in chapter 2. The materials 
used to fabricate these anastomosis devices as well as some potential biomaterials that 
can be used in such types of devices are also discussed in this chapter 2.  The 
description of the proposed new technique and the design of that new device as well as 
the selection of a material for this new device are illustrated in chapter 3. All 
experimental works including fabrication technique of the device and testing of this 
material are included into chapter 4 and 5. Finally, the conclusions and a brief 







Since the beginning of surgery, a wide variety of experimental studies have 
been conducted to develop alternative non-suture techniques to facilitate microvascular 
anastomosis. Some of them are only of historical interest, but some others are still 
being evaluated. However, this chapter is divided mainly into two parts. The first part 
reviews so far developed sutureless anastomosis devices or techniques including their 
applicability and their experimental or clinical results. Consecutively, the second part 
discusses the materials used for vascular anastomosis devices and some other 
commonly used materials in biomedical applications. 
 
2.2 Sutureless Vascular Anastomosis Device 
 
The alternative non-suture vascular anastomotic devices can be widely 
categorized as penetrating or non-penetrating coupling devices / rings, staple, laser 
welding and adhesive. All these techniques have some advantages over the suture 
technique which is now considered as the gold standard by which other techniques are 
evaluated. There are several international patents concerning sutureless vascular 
anastomosis, but most of them are only ideas, have some disadvantages and are still far 
from clinical use. Although these non-conventional techniques are not as new as they 
seem to be, but still they need some sort of improvement and a lot of experimental 
results to make them safer and widely accepted as well. 
 
Chapter 2   Literature Review 
 
6 
2.2.1 Coupling Device or Ring 
Evidence of coupling devices or various rings to facilitate vascular anastomosis 
can be found since 18th century. In 1894, Abbe [1] used a glass prosthesis to perform 
vascular anastomosis. Subsequently, lots of anastomotic devices by several researchers 
such as ivory cuff [2], parafined silver tube [3], shin bone of an ox [4] and so on have 
found their way into and around the vessels. A brief description of these early devices 
can be found in “History of mechanical devices and instruments for suturing” by 
Steichen and Ravitch [5]. Generally those early results were far away from ideal.  
In 1900, Payr [6] introduced an absorbable extraluminal magnesium ring 
design to facilitate vascular surgery. According to his design, the proximal end of the 
vessel was threaded through the metallic ring, everted its edge over the ring and 
anchored in place by a circumferential ligature. Then the ring with its everted vessel 
was inserted into the distal end. Finally, the anastomosis was completed by another 
circumferential ligature. Therefore, the magnesium ring acted as a supporting structure, 
thereby achieving intima-to-intima apposition. A few years later, in 1904 Payr [7] 
presented a new device consisting of two interlocking magnesium rings; where one 
end of the vessel is everted over the pins on one side of the ring. The pins passed 
through both vessels walls and holes of the matching ring. Finally the pins were bent to 
secure the anastomosis. Results showed that both devices were not comparable to those 
obtained with the suture technique. The reason for such failure was that magnesium 
becomes highly basic salt and provokes violent tissue reaction during absorption. 
However, those two techniques started a new era for vascular surgery and later have 
been modified by several researchers from time to time.  
Blakemore [8] advanced Payr’s technique by using rigid tubes made of 
vitallium that excites little tissue response. He got very good results, but later it was 
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found that this concept of inserting a non-absorbable tube had certain limitations 
especially when used in children because the vessel lumen at the anastomosis cannot 
increase in size during the subsequent growth of the patient. To eliminate this problem, 
Swenson et al. [9] introduced the fibrin tube, but using the same technique as that 
described by Blakemore. In his experimental group, one vessel out of twenty six had 
become obliterated by fibrosis due to extensive regional infection.  
At that time, World War II allowed huge clinical trials of both suture and non-
suture techniques. During that time, after an extensive review, vascular surgery suture 
techniques began to gain acceptance whilst on the other hand, interest in non-suture 
techniques waned. However, with the improvement of science and technology, people 
has understood that in the future, the suture technique would not be able to meet the 
increasing challenges of vascular surgery. Therefore, attention to non-suture 
techniques was renewed again.  
In 1961, Goetz et al. [10] introduced another device, again similar to Payr’s 
rings, but instead of magnesium, he used tantalum as his ring material. He used his 
device for coronary artery anastomosis on 12 dogs and his device showed better results 
than direct suture method on a beating heart.  
A year later, Nakayama et al. [11] developed another ring consisting of two 
identical metallic rings with six equally-spaced pins and holes, once again based on 
Payr’s second technique. That pinned ring could be used for vessel ranging from 
1.5mm to 4.0mm and the experimental model using that ring showed a good rate of 
patency.  
In 1983 Daniel et al. [12, 13] presented experimental and clinical reports of 
using a new absorbable coupling device made of Polyglactin (Vicryl Coupler from 
Ethicon Inc.). The device was absorbed by the host tissue within 50 to 70 days. Their 
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experimental and clinical results showed that there was a watertight intima-to-intima 
seal and a very good patency rate (203 out of 212 vessels i.e. almost 96%) and no 
intraluminal foreign body. However, in this technique, vessel ends need to be everted 
180º and that increases the chance for intimal damage and needs a skilled assistant 
also. Moreover, it wastes a greater amount of vessel than the pinned ring device and 
can be used neither for end-to-side anastomosis nor for significant vessel size 
discrepancy. Currently this absorbable coupler is no longer available for use.  
In 1986, Ostrup et al. [14] modified Nakayama’s technique and introduced 
another ring with complete instruments that is currently known as Unilink/3M® 
microvascular anastomotic coupling device. This Unilink/3M® coupling device 
consists of two high-density polyethylene rings with 12 stainless steel locking pins and 
is available in 1.0mm, 1.5mm, 2.0mm and 2.5mm size. So far, several experimental 
studies and a few clinical trials [15, 16] have been conducted using this ring. Patency 
rate and histological features have been found to be similar to those of conventional 
sutured anastomosis with the added advantage of greater mechanical strength. In 
Cope’s [16] clinical report, while everting the vessel over the ring it was found that 
two veins (out of 100) were torn out due to very thin walls. In the same study, two 
more veins that had very thick walls and reconstructed by using a 2.5mm coupler, 
resulted in significant reduction of the lumen. At that time, the system was thought to 
be an ideal method for mechanical anastomosis. However, one major problem of the 
Unilink device is that the rigid polyethylene ring remains permanently at the 
anastomotic site and that can lead to atrophy of the vessel wall and can induce acute 
foreign body reaction.  
To resolve those problems of Unilink system, Qu et al. [17] from Japan 
developed a similar but absorbable pinned ring coupling device for microvascular 
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anastomosis. Their device consists of two absorbable ring made of copolymer L-Lactic 
Acid and Glycolic Acid (L-lactic acid and Glycolic acid ratio was 7:3 by mole %) and 
six interlocking, hooked stainless steel pins. Their experimental study on rabbit 
showed 100% patency using this ring and vessel wall atrophy comparable with that of 
the Unilink system. However, although the ring would be dissolved by the host tissue, 
but similar to Unilink system in this device the pin would stay permanently, that can 
also elicit tissue response similar to the Unilink system. Chronic inflammatory 
reaction, especially in the adventitia was observed to be more intense and lasted for a 
longer time than for sutured anastomosis. Finally, the author expected in future to 
replace the stainless steel pin of his device by some kind of absorbable polymer, so 
that the whole device can dissolve after a certain time and thus would not affect the 
long term result. However, these devices (both UNILINK® and Wei’s device) need 
vessel wall eversion, which is not feasible for all kinds of vessels (e.g. very thin or 
very thick) [16]. Moreover, vessel eversion often causes endothelial damage and also 
need a skilled assistant.  
In 2001 Carrel et al. [18] introduced a new device (from St Jude Medical) (Fig. 
2.1 - 2.2) that can be used in heart bypass surgery to attach saphenous vein grafts to the 
aorta without sutures. St Jude calls this new device “The Symmetry™ Aortic 
Connector”. The connector is made of nitinol. In May 2001, the company has got the 
approval of Food and Drug Administration (FDA) for use in USA [19]. Since that 
time, almost 40,000 connectors have been used throughout the world and several 
clinical experiences have been reported by several groups. 




Figure 2.1 The Symmetry™ aortic 
connector [from St. Jude website] 
Figure 2.2 Anastomosis by using The 
Symmetry™ aortic connector [23] 
 
In a small clinical trial on 10 patients, Wiklund [20] reported that one sutured 
graft had significant stenosis and one connector anastomosis was occluded; overall 
patency rate was 90%. More recently, Carrel has reported his clinical experience of 
using this aortic connector on 107 patients who had received at least one connector 
with follow up to 6 months [21]. Within these 107 grafts, two connectors were 
removed finally due to excessive leakage and one connector due to incomplete 
deployment. Assessing the 24 vein grafts from randomly selected 14 people showed 
that there was 38% incidence of stenosis in the proximal anastomosis with graft 
connector, whereas no proximal hand-sewn anastomosis showed any significant 
stenosis. However, considering the limitations and pitfalls of the first generation 
proximal connectors, the ATG group of St. Jude Medical has developed a second 
generation of this connector. The trial of this system is still underway. However, Carrel 
(who had financial relationship with St. Jude) [22] reported that preliminary results 
seem to be better that those of the first generation. St. Jude has also developed a distal 
connector for Coronary Artery Bypass Grafting. Their animal testing showed that 
within the first generation, hemostasis was instantaneous in all cases but within the 
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second generation, one of five needs to be removed because of leakage [22]. All the 
anastomosis using this system was done without the use of aortic clamp. The system 
has not yet been tested for other types of vascular anastomosis. 
Beside these St. Jude’s devices, there is another proximal aortic connector, 
PAS-Port™ (Fig. 2.3 – 2.4) from Cardica, which has recently got European approval. 
This implant is made of stainless steel. There is only one size available for this 
connector and the system is compatible with vein grafts from 4 – 6 mm outer diameter 
and aortas with more than 18 mm diameter. Recently, a clinical trial has been 
conducted on 47 patients. The graft patency at discharge was 100% and at 6 months, it 
was 87%. The company has submitted data on this device for FDA clearance [22]. 
     
Figure 2.3 Cross-section view of 
PAS-Port™ [22] 
Figure 2.4 Inside view of PAS-Port™ in 
human aorta [22] 
 
Johnson & Johnson Co. in venture with Bypass Inc. of Israel has also tested a 
sutureless anastomotic device (The CoreLink Device) made of nitinol in small scale. 
However, this device is also waiting to get FDA clearance [23].  
These recently-developed ring (by St. Jude Medical and other companies also) 
are made of metal (Nitinol or Stainless Steel). Therefore, these devices would stay 
inside the body and that can affect long term patency and can cause inflammation as 
well. Moreover, the pins of these devices pass through the vessel walls and some 
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portion stay inside the vessel; hence they come into direct contact with blood which 
can also cause thrombus formation and turbulence in the blood flow. 
 
2.2.2 Laser Welding 
Research on laser welding has been ongoing since 1970. Basically, this 
technique is similar as that of normal welding. The energy from the laser changes the 
protein structure of the targeted tissue that results in the repair of the tissue through 
cross bonding of proteins. So far, a wide variety of lasers have been used for vascular 
surgery e.g. Infrared Carbon dioxide (CO2) laser [24], Thulium Yttrium Aluminum 
Garnet (Tm: YAG) laser, Neodymium: Yttrium – Aluminum Garnet (Nd: YAG) laser 
[25], GaAlAs semiconductor diode laser [26] and Argon laser [27].  
Most of the time, lasers are used in combination with different kinds of protein 
solutions. These proteins or protein-like substances are called “solders”. Solders are 
mainly used to create the anastomosis of sufficient strength to withstand the 
physiological environment. Laser irradiation heats the solder and causes denaturing of 
protein with subsequent cross-linking or unraveling and tangling of the protein chains. 
Therefore, lying as a film over the weld, solder enlarges the bonding surface of the 
weld, thus increasing the strength of the weld as well. Solder also acts as a heat sink; 
thereby reducing thermal damage. So far, several materials have been used as a solder 
material e.g. Fibrin, Egg albumin, human albumin [28], Bovine Serum albumin [29] 
and Porcine Serum Albumin [30]. Results of laser-assisted vascular surgery with the 
use of solder were significantly better than those of without using solder. However, 
since most of the solder is almost liquid, it is difficult to control the thickness and the 
surface area of the solder, thereby decreasing the reproducibility of the anastomotic 
results.  Several studies have been conducted on the use of solder in solid form like 
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membranes or strips. The latest innovation consists of a light-activated biodegradable 
solder polymer membrane consisting of poly (L-lactic-co-glycolic acid) (PLGA) [31]. 
Each tissue has its own wavelength-specific absorption coefficient e.g. the 
visible wavelength of light is mostly absorbed by blood, whereas infrared wavelength 
absorption predominantly occurs in water. Therefore, in order to laser heat the target 
tissue, the light must be of the right wavelength or color. In most cases, some kind of 
dye (often called Chromophore) is mixed with the solder material to facilitate 
absorption of the near-infrared light efficiently. Therefore, using chromophore reduces 
the required laser power and increases the anastomotic strength. Till now, several 
materials have been used as chromophore with protein-based solders for vascular 
surgery e.g. Fuschin, Fluroscein iso-thiocyanate, Indocyanine green dye [32] and 
Methylene Blue [33]. 
In fact, there are several parameters involved in determining the success of 
laser-assisted vascular anastomosis e.g. laser wavelength, power, power density or spot 
size, time of exposure and even types of laser, solder material and chromophore. 
Unfortunately, the optimal conditions for successful microvascular anastomosis have 
not yet been established. Therefore, there is no consistency among the reported results. 
Regarding the anastomotic strength or leak point pressure, recently-reported 
experimental results by Brich et al. [30] showed that the anastomosis were capable of 
withstanding very high pressures (1188 ± 222 mm Hg). Another study [32] showed 
that initially, sutured anastomosis are stronger than laser anastomoses (134.6 g and 
45.3 g respectively) although after 6 weeks, the strength of laser welded anastomoses 
is slightly higher than that of sutured anastomoses (134.2 g and 103.9 g respectively). 
However, initial low strength is one of the major drawbacks of laser welding since 
higher strength is necessary at the early stage of the anastomoses. 
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The application of laser for vascular surgery is quite tricky. The balance 
between over and under exposure of tissue is critical. Local exposure should be 
sufficiently short to prevent intimal damage by heat diffusion from the adventitia. On 
the other hand, for larger vessels in which the wall is thicker than in micro vessel, 
deeper penetration of laser light and heat are needed; which means tissue thickness is 
another important factor to cosider. However, laser is applied manually by hand and 
the time required for laser exposure to each spot is judged by the operator according to 
the appearance of the solder and degree of solder fade observed. That means this 
procedure also demands a proper proficiency of the operator, otherwise there is always 
a chance of burning the tissue. 
Laser is a source of heat. So this direct heating may also cause the thermal 
damage of the tissue and may hinder tissue regeneration, which is obviously 
unacceptable. This thermal damage can be reduced by reducing the laser power. In one 
experimental study, Mac Nally et al. [34] showed that the tensile strength of the 
anastomosis can be increased by increasing the laser power up to a certain limit, 
although further increasing drops the strength dramatically (because of thermal injury). 
However thermal damage can also be reduced to a great extent by changing the 
composition of the solder material and/or using chromophore together with solder 
material. As for example, using Methylene Blue as a chromophore in a solder reduces 
the power required to activate the solder, thereby reducing the thermal damage of 
tissue to a great extent [33].  
Unfortunately, there is no uniformity in the reported histological results. 
Several results show that there is a risk of formation of intimal hyperplasia, giant cell, 
stenosis, thrombosis or thermal injury. However, there is no definite relationship 
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between these and laser parameters [35]. Therefore, these techniques need further 
investigation before being applied to clinical practice. 
 
2.2.3 Staple 
This technique is based upon the same technique as the common stapling. The 
stapling device applies vascular clips with the shape of the African ant’s jaw and at the 
same time bends those clips into a B shape, thereby holding the vessels end together in 
contact with each other and securing the anastomosis (Fig. 2.5). 
 
Figure 2.5 Applying clips for vascular surgery 
 
In 1955, Samuels [36] described the use of metallic clips (stainless steel) in 
vascular surgery. A year later, Androsov [37] introduced a completely mechanized 
clipping system which used for both experimental and clinical end-to-end arterial 
repair and vein grafts. Then on the way of development, in 1980 Kirsch et al. [38] 
introduced a new approach to clipping the blood vessels. Both end-to-end and end-to-
side micro-vascular anastomosis could be carried out by this technique. Finally in 
1993, a modified version of this technique was approved by the Food and Drug 
Administration (FDA) USA under the name VCS® (Vessel Closure System) by United 
States Surgical Corporation (USSC, Norwalk, Connecticut).  
Currently available clipping systems are composed of a clip applier, specially 
designed everting forceps and a clip remover. Most of the commonly-used clips for 
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vascular anastomosis are made of titanium. Currently, clips are available in four 
different sizes: small (0.9 mm) (Fig. 2.6) medium (1.4 mm), large (clip dimension at 
the tip 2.0 mm) and extra large (3.0 mm). The size is based on the distance between the 
fully-open jaws of the clip. The number of the clips per cartridge depends on the clip 
size. Each cartridge contains 40 (small), 35 (medium) or 25 (large or extra large) clips 
[38].  
 
Figure 2.6 Small size VCS® clip [38] 
 
The recently-developed clip is designed in such a way that it does not penetrate 
the intima of vessel segments, so potentially thrombogenic material is excluded from 
the vessel lumen that is hardly possible in case of conventional suturing. However, 
Pikoulis et al. in 1998 [39] reported that in a few cases, the clip entered the lumen, but 
there was no thrombosis around the clip, whereas few other cases, thrombus had 
developed around silver clips in the lumen. Although theoretically, the clip is 
applicable to all kinds of vessels, in one clinical study Lorenzi et al. [40] reported that 
they failed to apply VCS staple in seven cases (out of 52); three due to confined 
anastomotic places, two because of small diameter vessel and another two because of 
inadequate eversion.  
Some researchers have shown that in terms of the patency or degree of 
narrowing, there is little difference between standard suturing and vascular clip [41, 
42]. Moreover Kirsch et al. [43] showed that there is a reduced rate of neointimal 
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hyperplasia with clipped anastomoses as compared to sutured anastomoses. The 
mechanical properties (tensile strength and burst pressure) of the clipped system and 
conventional suturing system are also comparable [44].  
The main problem with stapling is that it may change the elastic property of the 
vessel. This compliance drop may cause neointimal hyperplasia, which is the main 
cause of reocclusion following vascular surgery. Clipping also needs vessel evertion to 
a certain extent, which is not possible for all vessels (e.g. very thin and smaller 
diameter vessels or very thick vessels). Moreover, using clips to join the vessel of 
different diameters is more difficult than using suture technique. Clipping require more 
exact equalization than suturing. It causes foreign body reactions as well.  
 
2.2.4 Tissue Adhesive 
2.2.4.1 Several Types of Tissue Adhesive 
Tissue adhesives can be generally defined as any substance with characteristics 
that allow for polymerization and that polymerization must either hold tissues together 
or serve as a barrier to leakage [45]. The substance should be able to hold the tissue in 
place to allow the natural healing of cut or separated areas without any further support. 
So far, several types of adhesive has been developed for biomedical application e.g. 
Fibrin Glue, Cyanoacrylate (CN) Glue, Albumin-based compounds, Collagen-based 
compounds, Glutaraldehyde glues and Hydrogels. Considering bonding strength, CN 
glue is stronger than the other tissue adhesives [46].  
Fibrin Glue: The most basic fibrin glue consists of combinations of fibrinogen 
and thrombin. The compound becomes active when two components are mixed 
together. Full holding power is achieved within 3 – 5 min. However, to improve the 
bonding strength and applicability, some commercially available glue includes small 
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doses of calcium chloride, factor XIII or antifibrinolytics like aprotinin etc. One type 
of this fibrin glue is commercially available in the market under the brand name 
Tisseel VH (by Baxter Healthcare Corp., Westlake Village, CA, USA). However, the 
product description provided by the manufacturer of Tisseel VH fibrin glue shows that 
this fibrin glue is completely absorbed by the body within 10 to 14 days. 
Fibrin glue is quite effective in cardiovascular surgery for hemostasis. It can 
also be used as dural closure in neurosurgery to repair dural leaks and to prevent 
cerebrospinal fluid leak or plastic surgeons can also use this glue to control burn 
bleeding after debridement and as adjuncts in surgery necessitating flaps [45 – 47]. 
Among all types of surgical adhesive, fibrin glue has the longest history, and thus the 
widest range of applications. However, it has already been approved for clinical 
application in many countries including USA and Europe. But the major problem of 
this fibrin glue is being derived from human serum it always carries the theoretical risk 
of transmission of blood-borne diseases.  
Cyanoacrylate Glue (CN glue): Basically this glue has been developed to 
avoid the material of living origin in glue. A wide variety of cyanoacrylate adhesive 
(e.g. methyl butyl, isobutyl or octyl cyanoacrylate etc.) has been developed up to this 
time. Some types of which are now using for surgical purposes in Canada and Europe.  
These types of glue are very unstable monomer, stabilized by addition of a 
weak acid. Neutralizing the acid in the adhesive or coming the adhesive in contact with 
water or moisture or blood allows the cyanoacrylate to polymerize, i.e. form long 
chains of molecules and solidify. When applied properly, the glue starts to set after 1 – 
2 seconds and reaches its maximum mechanical strength within a minute. Finally, the 
glue detaches spontaneously within 7 – 10 days after application.  
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This type of glue has not yet got permission for use in all clinical purposes due 
to the fact of potential tissue toxicity [48]. Morever, it is not biodegradable. So it can 
elicit foreign body reaction that can cause inflammation.  Furthermore, it causes 
exothermic reaction during polymerization (the temperature can rise up to 45°C) that 
can damage the tissue. However, recently Johnson & Johnson Co. marketed a type of 
CN glue (2-Octyl CN glue as Dermabond™) that has fewer toxic effects and greater 
tensile strength as compared to older CN Glues, but this glue is restricted to use only 
for external use e.g. wound skin closure.  
However, fibrin glue is relatively expensive and difficult to prepare. On the 
other hand, CN glue is stronger than fibrin glue, easier to handle and can achieve the 
full holding strength very quickly. That is why some researchers are interested to use 
CN glue in cases of vascular reconstruction also. Recent experimental studies of Octyl-
Cyanoacrylate (OCA) glue for vascular anastomosis [49 – 50] failed to show any 
evidence of tissue toxicity to vessel wall and surrounding tissue. But still it needs more 
experimental works to prove it safe and to achieve wide acceptance for internal use.  
Albumin-based Glue: Beside this fibrin and CN glue, recently there is another 
type of surgical adhesive also available in market under the trade name BioGlue® 
Surgical Adhesive (by CryoLife Inc. Kennesaw, GA, USA). It is mainly a two-
component surgical adhesive composed of bovine serum albumin (45%) and 
glutaraldehyde. The compound becomes active once the two components are mixed 
together. It begins to polymerize within 20 to 30 seconds and reaches its full holding 
power within 2 mins regardless of the surrounding temperature and this occurs under 
water as well as with air exposure [51]. Finally the glue is absorbed by the body. 
However, the degradation rate of this glue is slower than that of fibrin glue. Technical 
information provided by the manufacturer company shows that usually it degrades 
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within 1 to 2 year depending upon the amount of the applied glue and the site of 
application. This glue has been already approved by FDA for internal use (e.g. thoracic 
aortic repair or cardiac surgery).  
In an experimental study of sutureless coronary anastomoses in vitro and in 
vivo Gundry et al. [52] showed very good adhesive properties of BioGlue. Hewitt et al. 
also [53] showed its usefulness in reducing postoperative blood loss in a sheep model, 
and also commented on the minimal inflammatory response evoked by BioGlue on 
histologic examination at 3 months. More recent experimental model presented by Van 
et al. [54] showed a good patency of 80% up to 3 months after initial construction. 
Although he found a little inflammatory reaction inside and outside the vessel around 
the glue, the detrimental reactivity adjacent to the tissue was minimal. However, 
several clinical studies [51 – 55] also prove BioGlue to be effective in its function as a 
hemostat, tissue strengthener and adherent if applied appropriately and without excess. 
 
2.2.4.2 Anastomosis by Using Tissue Adhesive 
As compared to other techniques, the idea of using adhesives for clinical 
purpose is quite new. Recently, the use of glue has gained interest in many areas of 
plastic surgery, such as wound healing, repair of nerves or blood vessel, skin grafts, 
face lifts and breast reconstructions etc. In 1965, Freeman reported the successful use 
of various substances including poly-urethane, silicone film, sodium edged Teflon 
tape, micropore adhesive tape to achieve sutureless anastomosis of small nerves [56-
57]. But during that time, the experimental results of vascular reconstruction using 
adhesives (both naturally-derived adhesives e.g. fibrin glue and other synthetic 
adhesives e.g. CN glue) tended to be less than satisfactory. These early experimental 
results show acute inflammatory reactions and suture line disruption. However, now a 
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days, it is well accepted that those problems may not be associated with the 
composition of the glue [58]. One of the major problems for using glue is excess glue 
deposition. Excess glue may run away and cause complications. Moreover, it often 
causes instant thrombus formation if it reaches the vessel lumen. Furthermore, the glue 
is almost liquid and that led to considerable difficulties in handling. So over the year, 
several researchers have tried several different modes of application to circumvent this 
problem.  
Matras et al. [59] reported the successful use of fibrin sealant for the first time 
in 1977. Then, Karl et al. [60] introduced a technique for using glue (fibrin glue) to 
perform end-to-end vascular anastomosis. According to his technique, the glue was 
applied after inserting one end of the vessel into the other end (well-known as the 
sleeve technique). Suture was used to hold the inserted vessel in position until the glue 
solidified. Finally, the retaining sutures were cut short and removed to complete the 
anastomosis. In his short experimental model of 14 days follow-up, he showed the 
patency in all 10 femoral arteries and 8 out of 10 veins.  
In 1982, Sully et al. [61] presented an experimental study of using glue in the 
case of end-to-end microvascular anastomosis by using a similar method. They used 
glue together with four stay sutures; two sutures to insert one end into the other, and 
another two to tie the outer free edge with the wall of the inner vessel. The last two 
sutures did not enter inside the lumen; just biting into the partial thickness of the wall. 
Theredore, this technique reduced the amount of suture material inside the lumen. 
Finally, the glue was applied at the outer edge to secure the anastomosis.  
At the same time, Borst et al. [62] presented a double syringe pressure-driven 
spray gun to apply the glue at the anastomotic site. In their clinical study on 340 
patients, they applied fibrin glue by a piece of collagen fleece (if applied as a small 
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amount) and by spray gun (if applied to large oozing surface) whenever conventional 
suturing appeared impossible, difficult or dangerous, with a success rate of 95%.   
In 1983, Gestring et al. [63] described a technique of using fibrin glue for doing 
end-to-side and side-to-side anastomosis. The author himself described his technique 
as tedious, difficult and time-consuming. He had limited success for smaller diameter 
vessels, because the technique needed to cut the vessel in a special way before 
applying the glue. However, according to their technique, the inserted end of the vessel 
remains hanging inside the other vessel and that may lead to severe blood flow 
impairment.  
In 1985, Sugiura et al. [64] used equal amounts of fibrinogen and thrombin 
solution and after mixing, put the resulting fibrin clot around the anastomosis. A few 
years later, Wadstrom et al. [65] also used the same technique of equal amounts of two 
solutions but with the help of a fully-mechanized double-syringe applicator and a 
special spray system (Duploject®). Subsequently, Han et al. [66] also tried to apply the 
fibrin glue at the anastomosis site by using an applicator gun. 
Aksik et al. [67] presented an experimental and clinical study of end-to-side 
microvascular anastomosis by using fibrin glue in combination with suture. He 
completed anastomosis by applying four crossed-fixing sutures and by covering a kind 
of haemostatic sponge muff impregnated with fibrin glue.  
In 1986, Sagi et al. [68] tried to use fibrin glue with the help of Vicryl Ring. He 
used the ring to evert the free end of the vessel and then applied glue on the 
anastomotic site. However, in his experiments all the anastomosis failed, implying that 
the strength of the glue itself is not sufficient if the contact area between the glue and 
the vessels is very small.  
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In 1996, Padubidri et al. [69] tried to apply fibrin glue like painting by brush in 
order to avoid excess deposition of the glue at the anastomosis site. However, he 
applied glue together with suture.  
Recently, Gundry et al. [52] has introduced a new technique to perform end-to-
side coronary anastomosis by using BioGlue with the help of a balloon catheter 
system. According to this technique, one catheter was placed inside the graft and 
another one in the coronary artery to hold the vessel together while applying the glue. 
The balloon catheter was then deflated and removed from the end of the graft 
simulating a side-to-side anastomosis. Finally, the open end of the graft was clipped, 
turning the anastomosis into an end-to-side fashion. However, this procedure is bit 
clumsy. In their in vivo studies in goat, they showed a good patency rate one year after 
vascular reconstruction by using BioGlue adhesive. Moreover, in their one year of 
follow up they could not find any significant inflammatory response or any detrimental 
reactivity of the glue to the surrounding tissue.  
More recently, Ong et al. [70] presented another experimental study of micro 
vascular anastomosis using OCA. In their study, to ensure no adhesive seeped through 
into the lumen during application, they at first used three stay sutures to hold the vessel 
ends together, then applied glue on the vessel wall with the help of a diced piece of fat 
as if using a paintbrush. In this study on 144 rats of six months follow-up, he showed a 
good patency rate (90%) with a better strength and very little inflammatory reaction 
with fewer foreign body granulomata. However, the study failed to prove any evidence 
of tissue toxicity caused by OCA.  
However, most of the study shows that the recently developed glue is safe in 
terms of its composition, but most of the difficulties are associated with the way of 
application of glue. Therefore, several researchers have tried several ways to apply the 
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glue properly. Thus, most researchers applied glue either by the sleeve technique or 
together with suture. The sleeve technique is technically rather cumbersome since one 
end of the vessel needs to be inserted into the other end. Moreover, the technique 
cannot be used if the vessel diameter is less than 1mm because of the fact that the 
narrowed down of the inserted portion increases the chance of vascular obstruction. 
Furthermore, this technique can not be used if there are differences between the vessel 
diameters. On the other hand, using glue together with end-to-end suture tends to either 
leak badly underneath the adhesive or require so many sutures that the adhesive offers 
little advantage. Since it only reduces the required number of stitches, the difficulties 
associated with stitching offset the advantages of using glue to a great extent. 
Moreover, there is always a chance that the liquid glue may seep into the lumen, 
causing thrombosis of the vessel.  
 
2.2.5 Ideal Anastomotic Device or Technique 
To facilitate vascular anastomosis, Payr first expressed the concepts of vessel 
eversion and pin technique in the early 1900. In the last 100 years, those techniques 
have been expressed in several different ways, without reaching remarkable clinical 
success; most probably because of technical and engineering limitations. Now they 
have been coupled with new materials and new advanced technologies (e.g. laser, 
staple etc.) to try to overcome the problems associated with those techniques. The ideal 
anastomotic device has to provide minimal graft manipulation, no limitation in 
anastomotic timing, no material inside the vessel lumen and optimal anastomotic angle 
for end-to-side anastomosis. However, virtually all the devices or techniques 
developed so far have some common disadvantages: (1) complex and cumbersome 
instrumentation and unsuitability for smaller-diameter vessels, (2) rigid foreign body 
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enclosing a dynamic dilating structure and (3) non-flexible technique, i.e. inapplicable 
for significant vessel size discrepancies. Therefore, to become widely accepted any 
newly developed anastomotic device should overcome these limitations as well as have 
the evidence of long-term effectiveness. 
 
2.3 Materials Used in Biomedical Application 
 
Since the beginning of the medical science, a wide variety of materials has 
been used for biomedical application. Literature shows that lots of material such as 
glass [1], ivory [2], silver [3], even shin bone of an ox [4] or magnesium [6] and so on 
have been used for vascular anastomosis device. However, later with the development 
of science most of those previously used materials have been proved not-suitable for 
being placed inside the human body. Consequently, new materials with more 
biocompatibility are being developed and finally, these new materials replace those 
previously used materials. However, materials used in the biomedical application can 
be widely classified into two groups, degradable and non-degradable materials. 
Materials under these groups are discussed in the following sections. 
 
2.3.1 Non-Degradable Material 
Among the materials under this group, stainless steel, titanium and nitinol are 
more popular ones. Recent examples of the use of these materials as a vascular 
anastomosis device are the Symmetry™ aortic connector (by St Jude; has already been 
approved by FDA) [18] or CoreLink Device (by Johnson & Johnson Co. in venture 
with Bypass Inc.; waiting for FDA approval) [23] made of nitinol; PAS-Port™ (by 
Cardica; has already got the European approval) [22] made of stainless steel etc.  
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However, the application of these non-degradable materials is currently very 
limited. Insufficient long term biocompatibility is one of the main reasons for this 
narrow usage of these non-degradable materials. Although currently most of these non-
degradable materials are well investigated and proven to have low toxicity, few of 
them have suitable long-term biocompatibility. There is often an immune-rejection or 
an encapsulation of these long lasting non-degradable foreign substances in vivo. 
Moreover, to carry those non-degradable implants throughout the whole life is quite 
uncomfortable too. So, in most cases, the implant needs to be removed from the site in 
order not to induce foreign body reaction or inflammation.  
 
2.3.2 Degradable Material 
Materials under this group are eventually absorbed by the body. Therefore, 
long-term biocompatibility is not required. So, the patient needs not go for any further 
surgery to remove the implant. Evidence of using absorbable materials as a ring or tube 
to facilitate vascular anastomosis can be found since the middle of the last century. As 
for example, in 1947, Swenson et al. [9] used fibrin tube for vascular anastomosis. 
Subsequently, several materials by several researchers such as polyglactin [12], 
copolymer of L-lactic acid and glycolic acid (PLGA) [17] etc. have been also used to 
fabricate vascular anastomosis device.  
Now a days, a wide variety of biocompatible and biodegradable materials are 
available in the market. Within these biodegradable polymer, in particular those 
fabricated from the α–hydroxy acids (aliphatic polyesters), have been used clinically 
for more than four decades. This type of polymer is mainly produced by condensation 
polymerization of saturated aliphatic α–hydroxy acids. Polyhydroxyalkanonate (PHA) 
is the general term for this kind of polyesters. In addition, there are some naturally 
Chapter 2   Literature Review 
 
27 
derived PHAs also available e.g. Poly (β-hydroxy butylate) (PHB), but because of their 
slow degradation in the human body, these materials have not been widely applied for 
medical applications [71]. Besides these, currently a variety of biodegradable and 
biocompatible material/composites have been developed e.g. blends of Poly (ε -
Caprolactone) and Poly (Vinyl Acetate) [72], Composite of Poly (L-Lactide) & 
Bioactive Glass [73] etc.  
However, most of these recently developed materials are still under 
investigation and are not ready for practical applications. On the other hand, in 
biomedical field, the first practical application of PHA (PLA for bone prosthesis 
material in oral surgery) has been reported by Kulkarni et al in 1966 [74]. Moreover, 
currently the materials under this group have already been approved and widely 
accepted for use in biomedical as well as pharmaceutical applications because of their 
well-proven biocompatibility, biodegradability and toxicological safety. That is why 
the focus has been concentrated on the materials under this group only.  
 
2.4 Polyhydroxyalkanonate (PHA): The Most Commonly Used 
Biomaterials 
 
Polyhydroxyalkanonate is a general terms of those polymers derived from 
condensation polymerization of saturated aliphatic α–hydroxy acids. The most widely 
used materials in this group are:  
 Poly (Glycolic Acid) (PGA),  
 Poly (Lactic Acid) (PLA),  
 Poly (ε-Caprolactone) (PCL), and  
 Co-polymer of these materials (e.g. PLGA, P(LA/CL), P(GA/CL) etc.) with 
different ratios of the homo-polymer.  
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The chemical composition of PGA, PLA and PCL has been given in Fig. 2.7. 
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Figure 2.7: Chemical composition of PGA, PLA and PCL 
 
2.4.1 Poly (glycolic acid) (PGA) 
It is the simplest linear aliphatic polyester. Usually, PGA is highly crystalline 
and has high melting point and low solubility in organic solvents [75]. PGA was used 
in the development of the first totally synthetic absorbable suture by American 
Cyanamid and finally, PGA sutures have been commercially available under the trade 
name Dexon™ since 1970 [76]. Owing to the hydrophilic nature of PGA Dexon™ 
sutures tend to lose their mechanical strength rapidly, typically within 2 to 4 week after 
implantation [77]. 
 
2.4.2 Poly (lactic acid) (PLA)  
It is prepared from cyclic diester of lactic acid by either ring-opening 
polymerization or condensation polymerization. Owing to the presence of an extra 
methyl group in lactic acid, PLA is more hydrophobic than PGA [77]. Therefore, it 
degrades much slower than PGA, but in organic solvents it is more soluble than PGA. 
Depending upon polymer morphology and site of application usually it takes 2 to 5 
years to be fully dissolved by the body [78]. Since, PGA degrades very fast, so if the 
implanted amount is large, then often the degradation products evoke inflammatory 
reaction in the tissue [71], which hinders tissue regeneration also. However, copolymer 
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of PGA and PLA is often used to adapt these materials properties to a wider range of 
possible applications e.g. a multifilament suture marketed under the trade names 
Vicryl™ and Polyglactin 910™ which is composed of 90% of GA and 10% of LA [79] 
and now is considered as the typical type of biodegradable suture. 
Since lactic acid is a chiral molecule, it exists in two stereoisomeric forms 
which give rise to four morphologically distinct polymers. D-PLA (also known as 
PDLA) and L-PLA (also known as PLLA) are the two stereoregular polymers; D,L-PLA 
is the racemic polymer obtained from a mixture of D- and L- lactic acid and meso-PLA 
can be obtained from D,L-lactide. However, meso-PLA is not often used in practice, so 
it would not be discussed further.  
The polymers derived from the optically active D and L monomers are 
semicrystalline whereas the optically inactive D,L-PLA is always amorphous. The 
mechanical properties and degradation kinetics of the semi-crystalline L-PLA or D-PLA 
is completely different than those of completely amorphous D,L-PLA. Usually L-PLA is 
employed more frequently than D-PLA, since its hydrolysis yields naturally occurring 
stereoisomer of lactic acid. However, semicrystalline L-PLA is preferred in 
applications where high mechanical strength and toughness are required e.g. suture, 
orthopedic device etc. [80,81], whereas D,L-PLA is usually considered for applications 
such as drug delivery, where it is important to achieve a homogeneous dispersion of 
the active species within a monophasic matrix [82]. 
 
2.4.3 Poly (ε-caprolactone) (PCL)  
It can be synthesized from ε-caprolactone.  Initially, it was thought that PCL 
can be degraded only by micro-organism, so its usage was limited only as a 
biodegradable packaging material [71]. But later it was discovered that PCL can also 
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be degraded by a hydrolytic mechanism under physiological condition [83]. After that 
it has been widely investigated as a potential biomaterial. The degradation of PCL is 
significantly slower than that of PGA and PLA. It is also a semicrystalline polymer and 
has a very low glass transition temperature (Tg) of about -60ºC and also a very low 
melting temperature of about 57ºC [71]. Therefore, it is always in a rubbery state at 
room temperature. Because of its exceptionally lower Tg and slower degradation, it has 
so far been predominantly considered for controlled release drug-delivery applications. 
Another interesting property that has made PCL more suitable for drug delivery is its 
propensity to form compatible blends with a wide range of other materials [84].  
Literature review reveals that the mechanical properties (tensile or compressive 
strength and modulus), thermal properties or degradation kinetics (time to be dissolved 
or time to lose the mechanical strength) of these polymers depend upon a lot of factors 
e.g. molecular weight (Mw), its distribution and orientation, crystallinity etc. which in 
turns is a function of the way the test samples are prepared. Therefore, published 
results often cannot be used for direct comparison of different polymers. However, a 
comparative study on these polymers has been found in literature [85], where the 
author used a total no. of 20 degradable polymers (including the various available 
molecular composition within a given family of polymer) to compare their mechanical 
and thermal properties. For better comparision, the author prepared all samples by 
solvent casting and/or compression molding (depending upon the specific polymer) in 
the form of film with 0.15 ~ 0.20 mm thickness. The study shows that, tensile strength 
of PLLA varies from 28 to 50 MPa, for PDLA it is 20 to 35 MPa and for PCL it is 16 
MPa. For better comparison the brief summary of their reported result (mechanical and 
thermal properties) is given in Appendix A.  
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However, these values are not absolute. With the development of technology, 
currently the effects of processing parameters are better understood. Therefore, now a 
days, polymer of the same family have often been prepared in a variety of molecular 
compositions with improved mechanical properties by fine-tuning the processing 
parameters (e.g. for molding mold temperature or injecting pressure [86]; for 
producing fiber draw ratio or drawing speed [87 – 88] etc.) or even controlling the 










After going through an extensive literature review on so far developed 
anastomotic devices, we can briefly summarize their advantages and disadvantages as 
follows: 
Laser: Laser acts as a heat source, so there is always a chance of burning the 
tissue which is absolutely unacceptable. Furthermore, laser is applied by hand and the 
time required for laser exposure is determined by the operator according to the 
appearance of the solder and according to the thickness of the target tissue. Therefore, 
it needs some sort of skill of the operator; consequently, it makes the technique more 
difficult to reproduce the anastomotic result. 
Staple: This technique works fast, but it requires more exact equalization of the 
vessel; therefore this technique also needs a skilled operator. Moreover, those metallic 
pins may affect long term patency, and to carry those staple pins throughout the whole 
life is also uncomfortable and undesirable. Furthermore, it needs considerable force for 
bending the staple pin or clips and if the anastomosis is aborted, the vessel edges have 
to be trimmed. Therefore, it is more traumatic to the vessel than conventional suture. 
Adhesive: Tissue adhesive may give rise to allergic reactions and anaphylaxis, 
although recent glues have already been proved safe to tissue. However, the major 
problems are that the glue itself is not strong enough to hold the vessel together, and 
the outcome of the anastomosis largely depends upon the efficacy of applying glue. In 
fact the application of the glue is quite tricky, because it is almost liquid and there is 
always a potential risk that it may enter the vessel lumen. 




Ring: Intraluminal stents or rings have low patency rates and hence are not 
suitable for vascular anastomosis especially for smaller diameter vessel. In contrast, 
the extraluminal ring has a good patency rates. But, in extraluminal rings the 
attachment of the vessel is accomplished either by everting the vessel on the ring or by 
using metallic pins passing through the vessels. However, everting of vessel consumes 
a considerable amount of vessel and it is not possible to evert all types of vessel (e.g. 
very thin or very thick wall vessels). So, sometimes it causes intimal damage and even 
tears out the vessels also. The long-term presence of metallic pins passing through the 
vessel wall induces foreign body reaction that can also affect long-term patency. 
Moreover, currently most of the commercially available ring is mainly for the larger 
diameter vessel as like aorta.  
The main objective of this project is to come up with the concept of a micro-
anastomosis device that would make the procedure easy and would help the surgeon to 
speed up the anastomotic procedure without compromising the quality of the 
anastomosis. However, as compared with other techniques, extraluminal rings seem 
more suitable and promising. Therefore, taking into consideration the limitations of a 
ring it has been decided that a new ring be developed with the following desired 
criteria: 
 The ring should be capable to join the smaller diameter vessel (e.g. 2mm 
or smaller than that).  
 The ring would be placed entirely outside of the vessel lumen; therefore, 
there would not be any material inside the lumen.  
 The ring would secure the vessel neither using pin pass through vessel nor 
using vessel evertion.  




 The ring would give support to the vessel until it heals properly, after that 
entire ring would be dissolved by the body. 
Now taking consideration those above mentioned desired criteria, a new 
anastomotic technique has been proposed that consists of an absorbable extraluminal 
ring in combination with glue. According to this technique, the vessel would be 
attached to the ring by glue and thereafter the ring would be used as a coupling device. 
Hence, there will be no necessity for vessel eversion or to use any pin for attaching the 
vessel to the ring. Theoretically there would not be any material inside the vessel 
lumen too. The detail anastomosis technique is described in the following section. 
 
3.2 Description of the Technique  
 
According to the proposed anastomosis technique, the entire anastomosis 
procedure can be divided into two main steps. The first step is attaching each vessel 
ends (those are intended to join) with two different rings and the second step is locking 
the rings loaded with vessel.  
However, attaching a vessel end with a ring would be accomplished with the 
following few steps: 
 Pulling the vessel end through the ring and then slid over a deflated balloon 
catheter with the help of a thread passing through the vessel wall (Fig. 3.1). 
The technical specification of such kind of catheter is given in the 
Appendix B. 
 Inflating the catheter and still holding the thread with the catheter to 
maintain the luminal integrity (Fig. 3.2). 
 Applying the glue over the outer wall of the vessel by using the standard 
applicator gun and tip (supplied by the manufacturer of the glue) and 




thereafter, uniformly spreading the glue over the vessel wall by using a 
deiced piece of excised inguinal fat held by a pair of jeweler’s forceps just 
like as a paint-brush (as described by Ang et al. [49]). (Fig. 3.2) 
 Pulling back the vessel (keeping the inflated balloon catheter inside the 
vessel) to place its end at the end face of the ring. Thereafter, pressing the 
vessel wall against the ring by further inflating the balloon catheter as 
requirement to ensure total surface contact of the vessel outer wall with the 
ring tunnel (Fig. 3.3). 
 Allowing some time (as specified by the manufacturer of the glue) to let the 
glue to polymerize and to achieve its full holding strength and slowly 
removing the thread; thereby, it allows attaching the vessel end with the 
ring (Fig. 3.3).  
 Finally, deflating the catheter and removing it from the vessel attached with 
ring (Fig. 3.4). 
Thus the attachment of one end of the vessel with one ring is accomplished. 
The ring with attached blood vessel is shown in (Fig. 3.5). The other vessel end would 
also be attached with another ring in the same way as described above.  
The second step is very simple. The two rings, with attached vessel ends, 
would be joined together by bar a lock and thereby completing the entire anastomosis 
procedure (Fig. 3.6). 





Figure 3.1 Pulling vessel end through the ring and then slid over the balloon catheter 
by pulling a thread passing through the vessel 
 
Figure 3.2 Placing the vessel over balloon catheter and applying glue over the 
vessel surface 
Pulling the thread in order to pass 
the vessel through the ring and to 
slid over the balloon catheter 
Applying glue over 
the surface of the 
vessel 





Figure 3.3 Pulling back the vessel to fix it with the ring 
 





Pulling back the vessel 
together with balloon 
catheter inside it 
In order to attach the vessel 
with the ring, inflate the 
balloon catheter as 
requirements and hold it as 
it is to allow sufficient time 
for glue polymerization 





Figure 3.5 Blood vessel attached with ring 
 
 
Figure 3.6 Complete anastomosis by using combination of ring and glue 




Basically this ring technique has been adapted from an earlier reported surgical 
approach for vascular surgery using magnesium ring described by Payr in 1900. Later 
throughout the whole century, the same approach has also been tried by several 
researchers in many ways in combination with different materials. But unlike to those 
studies, here in this study the attachment of the vessel with the ring is accomplished by 
using simply glue instead of folding back the vessel over the tube/ring and using 
circumferential ligature or pin. Finally, those two rings loaded with vessel are locked 
with each other, causing the two vessel segments to be approximated intima to intima 
until the vessel ends heal properly.  
According to this design, there should be different sizes of the ring for different 
vessels. Since the vessel could be attached to the ring with a bit of stretching, this 
technique would be able to accommodate a little bit discrepancy of vessel sizes. 
However, this technique can not be used for end-to-side anastomosis. Another thing to 
note is that is the end face of the vessel should be properly aligned with the end face of 
the ring. Otherwise, if the vessel ends do not come in contact with each other properly 
then it may affect the regeneration of the tissue. The design of the ring and bar lock for 
the proposed new technique is shown in the following section.  
 
3.3 First Proposed Design of the Ring 
 
This proposed technique needs different sized rings for different sizes of the 
vessels. As mentioned earlier, microvascular surgery usually refers to the surgery on 
artery or vein of less than 2.5mm diameter, so at first, to demonstrate the idea only one 
size of the vessel (2mm diameter) is considered. Throughout the whole work, the focus 
will be only on the 2mm diameter vessel. The first proposed designs for the ring and 
bar lock are shown in Figs. 3.7 – 3.8. The detailed drawings are given in the Appendix 




D (Figs. D1 – D2). However, one thing should be mentioned that the dimensions 
shown in this study is not the optimal size of the ring. Since the objective of the study 
is to come up with a concept of an anastomosis device and to demonstrate the idea by 
fabricating the device model, so for instance, no critical stress analysis is done or no 
environmental effect is considered.  
 
Figure 3.7 The ring (all dimensions are in mm) 
 
Figure 3.8 The bar lock (all dimensions are in mm) 




3.4 Model Development 
 
Based on the above design a test model of the ring and bar lock system is 
fabricated out of acrylic (Fig 3.6). In the test, a plastic tube (diameter 2.0 mm, 
thickness 0.75 mm) is used instead of an actual blood vessel. Super glue is used to 
attach the ring with the vessel wall. Finally, the anastomosis is completed by using the 
technique described in section 3.2. 
  
Figure 3.9 Model of the anastomosis by using acrylic ring and plastic tube 
The model is tested for leakage only. A hydraulic jack is used to give a 
pressure from one end of the plastic tube and a pressure gauge is connected to the 
opposite end. The model did not show any sign of leakage up to the normal systolic 
blood pressure (120 mm Hg or 2.3 psi). A small amount of leakage was detected only 
after the pressure was further increased to about 6 psi (2.5 times of the normal 
pressure).  
 
3.5 Modified Design of the Ring  
 
According to the above proposed design, the complete set of the system 
comprises four parts (two side of the ring and two bar locks). Since the ring as well as 
bar lock are very small, so it is very easy to unintentionally drop and lose any piece 




inside the body during an operation which is undesirable. To avoid this, a new 
modified design of the ring (Figs 3.10 – 3.11) is proposed that has only two parts. 
Instead of using the bar locks of the previous design, here the two rings can be locked 
by simply rotating each other (Fig. 3.12). The basic anastomotic procedure remains 
unchanged.  The detailed drawings of these rings are given in Appendix D (Figs. D3 – 
D4). 
 
Figure 3.10 Male port (one side of the ring set) (all dimensions are in mm) 
 
 
Figure 3.11 Female port (another side of the ring set) (all dimensions are in mm) 





Figure 3.12 The complete anastomosis using two rings 
(male port and female port) in combination with glue 
 
This technique needs some precautions too, for example 
 The end face of the vessel should be properly aligned with the end face of 
the ring. Otherwise, if the vessel ends do not come in contact with each 
other properly then it may affect the regeneration of the tissue.  
 The rotation of the ring while locking unto each other (the total angle of 
rotation with relative to each other is 45º) also twists the vessel. Therefore, 
there is the possibility of complications caused from this twisting of the 
vessel. To avoid any complications, the vessels need to be rotated in the 








3.6 Selecting the Ring Material 
 
3.6.1 Desired Criteria for Ring Material 
The proposed anastomotic technique is based on an interlocking pair of rings 
and glue. The ring would give support to the vessel until it heals properly. Therefore, 
the ring plays an important role in this proposed technique. Hence, selection of a 
material according to the desired criteria of the ring is very important, and ideally, it 
should satisfy the following criteria: 
 Bio-inertness: It must be inert in response with tissue i.e. it should be non-
pyrogenic, non-hemolytic, non-mutagenic and non-toxic to tissue.  
 Biocompatibility: It should not cause any inflammation or foreign body 
reaction to the host tissue.  
 Sterilability: The material should be able to be sterilized by normal 
procedures e.g. radio-irradiation (e.g. UV ray or γ-ray), autoclaving, etc.  
 Biodegradability: According to the proposed technique, the ring should be 
dissolved after a certain period of time in order to avoid any long-term 
effect (e.g. inflammation or foreign body reaction) at the anastomosis site. 
Since, the ring acts as a supporting structure of the vessel, so after healing 
there is no more necessity for the ring to stay inside. Usually, for suture 
anastomosis complete coverage of endothelium is reestablished within two 
weeks and complete healing takes not over than three months [12], so the 
ideal ring should also degrade within two to three months. Beside this, the 
degraded substances must be biocompatible and non-toxic too.  
 Physical and Mechanical Properties: The strength of the ring material 
must be sufficient to hold the blood vessel under pulsating pressure 
conditions and to retain the vessel shape. Moreover, the material should be 




able to undergo conventional forming process e.g. casting, injection 
molding, machining, etc.  
 
3.6.2 Selected Ring Material 
Literature shows that a wide variety of biocompatible and biodegradable 
material has been developed so far and still research is going on to develop material 
having desired mechanical strength and rate of degradation (e.g. rate of losing strength 
or losing mass etc.) to meet the requirements of a particular application. However, 
after going through an extensive literature review on these materials and their 
applications, it has been found that polymers those derived from α-hydroxy acids 
(aliphatic polyester) (commonly known as Polyhydroxyalkanonate or PHA) are the 
most well approved materials for clinical use. Nowadays, the materials under this 
group are used for a wide range of biomedical applications, such as in surgery as a 
suture, in orthopedics as a bone plate or screw, in tissue engineering as a scaffold or 
even in drug delivery also. Therefore, it is also decided that the material under this 
group be used for this new anastomosis device because of their well-proven 
biocompatibility, biodegradability and toxicological safety.  
As described earlier in the literature review, the materials in this group are: 
PGA, PLA, PCL and the copolymers of these materials. Within these three homo-
polymers, PGA degrades the fastest (fully dissolved usually within 2 ~ 4 weeks) and is 
mostly used as a suture material. On the other hand, PLA degrades slower than PGA 
(fully dissolved usually within 2 ~ 5 years) and its processability is much better than 
that of PGA. That is why nowadays, PLA is considered for much wider applications 
e.g. suture reinforcement, bone plate, screw, pin etc. PCL is used mostly for drug 
delivery systems because of its very slow degradation and for the capability to form 




compatible blends with a wide range of other materials. Therefore, by taking into 
consideration all the characteristics (mechanical properties, degradation kinetics and 
processability) of these materials, and comparing with the desired criteria for the 
proposed anastomotic ring, it is decided that PLA be used for the fabrication of the 
ring prototype.  
Now within the four existing forms of PLA (i.e. L-PLA, D-PLA, D,L-PLA and 
meso-PLA), literature review reveals that L-PLA is usually preferred in applications 
where high mechanical strength and toughness are required. For this reason and also 
because of easier availability, L-PLA (also known as PLLA) is finally chosen as the 
ring material. 
 
3.7 Selecting the Glue 
 
3.7.1 Desired Criteria for Glue 
According to the proposed anastomotic technique, the ring would give support 
to the vessel until it heals properly, and the vessel would be attached to the ring with 
the help of glue. Therefore, glue plays an important role in this proposed technique. 
Moreover, the glue would be used inside the human body. That is why, selection of 
glue for this anastomosis device is very critical, and ideally, it should have the 
following desired criteria: 
 Biocompatibility: It should not cause any inflammation or foreign body 
reaction to the host tissue.  
 Bio-inertness: It must be inert in response with tissue i.e. it should be non-
toxic, non-pyrogenic and non-mutagenic to tissue.  
 Biodegradability: Not only should the ring degrade after the healing of the 
blood vessel, the glue should also degrade after anastomosis has taken place 




to avoid any long term complications. Another point that should be 
considered is the locking site which is the weakest point of the ring. So 
once degradation starts, the locking site will be loosened first and hence, 
the ring pair may be unlocked. Therefore, the glue should be active until the 
rings dissolve to avoid any unnecessary to and forth movement of the ring 
along the vessel. So, after anastomosis takes place, ideally the ring should 
be dissolved first, and then gradually, the glue should be dissolved as well.  
 
3.7.2 Selected Glue 
Literature shows that there are several types of glue currently available in the 
market and research is still ongoing to improve the strength and rate of degradation of 
the glue to meet the requirements of a wide range of application. Within these glues, 
fibrin glue, CN glue and bioglue are more widely used. Since CN glue is not 
degradable, it is only restricted for external use; and hence cannot be used in this 
proposed new technique. On the other hand, fibrin glue is completely absorbed by the 
body within 10 to 14 days, whereas bioglue is within 1 to 2 year. Moreover, several 
literatures have proven that both of these glues are biocompatible and can be used 
inside the human body. Furthermore, both of these glues are approved by FDA for 
clinical application. Therefore, taking into account the desired criteria, it is decided 
that bioglue (by CryoLife Inc. GA, USA) be used for this new proposed device. The 
glue specification is included in Appendix C. 
From experience, it has been found that pulling a blood vessel through such 
kind of ring does not take more than 2 min. Moreover, this bioglue reaches its full 
holding power within 2 min. So, it can be expected that attaching one end of the vessel 
with one ring would not take more than 5 min, and as a result, it can be expected that 




the entire anastomosis would be completed within 10 min. However, from the testing 
of the model, it is apparent that this method is quite satisfactory. But, it is not possible 
to predict what will happen in the case of actual anastomosis as the proposed 
anastomosis techniques are based on the glue and glue properties (e.g. strength and 
leak proofing) depends on the surface property of the mating components as well as 
the glue. Besides this, blood vessels are softer and thinner than the plastic tube that was 
used in the test. Moreover, some vessels are easily collapsible. That is why the 







This chapter is mainly divided into two parts. The first part describes the 
testing of the material that is selected for the ring and the second part describes the 
fabrication technique of the ring with that selected material. 
 
4.1 Testing of the Ring Material 
 
PLLA is highly sensitive to melt temperature and moisture. It is well 
documented that the processing technique and temperature in combination with the 
grade used have a great influence on the mechanical properties and the degradation 
kinetics of the resulting molding [86]. Therefore, it is essential to check the properties 
of the molded material (mechanical strength and degradation behavior) before doing 
any in – vivo animal tests with the ring.  
 
4.1.1 Methodology 
4.1.1.1 Material  
The semi-crystalline Poly (L-Lactide) (PLA) used in this entire study was 
obtained in the form of pellet from Absorbable Polymers International, 2683 Pelham 
Parkway, Pelham, AL 35124 USA (formerly known as Birmingham Polymers Inc.). 
The pellet had inherent viscosity of 1.09 dl/g (at 30ºC in Chloroform) as specified by 
the supplier and the melting point of 170ºC, glass transition temperature of 52ºC and 
crystallinity of 9% was determined by Differential Scanning calorimetry (DSC). 
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4.1.1.2 Sample preparation (Casting)  
For casting, the PLLA pellets as received from the supplier were first put into a 
small container and then heated up to a temperature of 190ºC for about 20 minutes to 
melt pellets by using a convection air forced heater. There is a small hole at the bottom 
of the container to facilitate the pouring of the liquid into the mold cavity. After 
melting of the PLLA pellets, the container having the liquid PLLA was placed onto the 
top of the mold, and hence the liquid flowed down and filled up the mold cavity due to 
natural gravitational force. No external force was applied to force down the liquid into 
the mold cavity. To maintain the uniform temperature, before pouring the liquid, the 
mold was also kept inside the heater, so that the liquid and mold temperatures are the 
same. 190ºC was chosen to ensure sufficient liquidity to allow the liquid to flow over 
the mold. However, liquid PLLA is too viscous to pour into the mold instantly, so it 
needs some time for the liquid to fill up the mold cavity. To maintain the temperature 
throughout the entire procedure of casting (melting and pouring of the liquid polymer 
into the mold) the mold and the container were kept inside the oven. 
After filling up the mold cavity by liquid polymer, the mold was taken out of 
the heater and cooled down in the normal atmosphere. No quenching or rapid cooling 
was done. The total process was completed within 50 minutes. Both the mold and the 
container used were made of aluminum. 
Formation of voids within the molded product is a common problem in casting. 
To avoid this, it is recommended to melt the powdered or pellet form of plastic into a 
container and then pour into the mold in such a way that the liquid enters the cavity 
from one side, fills up the cavity and then the excess amount goes out through another 
side. The same procedure was also followed here instead of just melting the polymer 
pellet inside the mold cavity. Since PLLA is almost transparent, only visual inspection 
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was done to check the void. Therefore, the samples did not use in the test if any void 
can detect visually. 
 
4.1.1.3 Sterilization 
Sterilization of this kind of biodegradable polymer changes the molecular 
weight and/or structure of the polymer that in turn affects the mechanical and physical 
properties of the material. Since the test is intended to be representative of actual 
performance in vivo, it is recommended by ASTM standard F1925 to sterilize all the 
test samples consistent with that of the final device. In this study, all of the test 
samples were sterilized by using ultraviolet (UV) radiation for 2 hours.  
 
4.1.1.4 In-Vitro Studies 
In vitro studies (weight loss, tensile and compression test) were performed in 
1X Phosphate-Buffered Saline (PBS) solution up to eight weeks. No anti-microbial 
additive was added into PBS. Each sample was kept into a different centrifuge tube 
(50ml). These containers together with samples immersed in PBS were kept in a 
heated air oven throughout the testing period (Fig. 4.1), to simulate the human body 
temperature of 37 ± 2ºC. To simulate the physiologic condition, pH of the PBS was 
maintained at 7.4 ± 0.2 and to do so, pH was checked (by using a pH meter) regularly 
after every three days and the solution was changed once per week. Furthermore, to 
maintain stable aging conditions, the solution/specimen ratios were kept within 90:1 to 
100:1.  




Figure 4.1 Keeping the samples inside the oven to 
maintain constant temperature 
 
4.1.2 Experimental Procedure 
4.1.2.1 Thermal Analysis (Differential Scanning Calorimetry) 
The thermal properties (i.e. melting temperature, glass transition temperature 
and crystallinity) of the virgin PLLA (raw material as received from the supplier in the 
form of pellet) were determined by differential scanning calorimetry (DSC) using the 
Perkin-Elmer Pyris 6 Thermal Analyzer (Perkin Elmer, CT, USA) according to ASTM 
standard D3417-99 and D3418-03. In order to investigate the change in micro-
structure due to melting, DSC was also performed on the sample after molding. This 
sample was prepared by cutting (using a sharp blade) a thin section of about 1mm 
orthogonal to the melt flow direction from the middle of the molded specimen. The 
samples weighed between about 5mg to 8mg. 
The samples were heated from 20°C to 230°C with a heating rate of 
10°C/minin in nitrogen atmosphere (nitrogen flushing at 20ml/min). A second scan 
was also performed under the same conditions after quenching the sample (with a 
cooling rate of about 100°C/min) at the end of the first run.  
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The glass transition temperature (Tg) was determined from the baseline shifts 
on the thermogram. The crystallinity content of the specimens was determined by 
rating the difference between enthalpies of melting and crystallization peaks to the 
reference melting enthalpy of 100% crystalline polymer (Hm=93.7 J/g [91]) 
 
4.1.2.2 Weight Loss Test 
A weight loss test was performed on the molded PLLA up to eight weeks 
according to ASTM Standard F1635-04. A digital weight balance (Mettler Toledo, AB 
304-S Switzerland) of range 10mg to 320gm, sensitivity 0.1mg was used to measure 
the weight of the samples. 
The samples were prepared by casting PLLA (as described in the earlier section 
4.1.1.2) into the shape of flat strips having a cross-section of 5.0mm X 2.0mm and then 
cut into strips of about 15 mm to 20 mm length by using a sharp blade. All the samples 
were sterilized as described in section 4.1.1.3 before starting the test. 
After taking the initial weight, all of the samples were soaked in PBS solution 
for up to eight weeks by following the procedure described in section 4.1.1.4. At the 
end of every week, five samples were taken out from the solution and gently rinsed 
with distilled water to remove the saline. Finally, the samples were placed on a tray 
inside a dry box with silica gel. The weight of the samples was recorded after seven 
days of drying when the weight of the samples had become stable.  
 
4.1.2.3 Tensile Test  
Mechanical tensile properties (Ultimate Tensile Strength, Breaking Strain and 
Modulus of Elasticity) of the molded PLLA and the change of these properties were 
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investigated for up to eight weeks. The test was carried out by using an Instron Tensile 
Testing Machine (Fig. 4.2) having a ±1kN load cell.   
 
Figure 4.2 Instron machine 
The samples were prepared by casting of virgin PLLA (as described in section 
4.1.1.2) into the shape of a flat strip having 2.0mm X 6.0mm cross-section and then 
cutting the flat strip into a dumb-bell shape of rectangular cross-section (2X3 mm2) 
and gauge length of 20.0mm by using a milling machine. The dimensions are chosen 
as specified by Pistner et al. [92]. A pneumatic gripper (air pressure 6.0 ∼ 6.5psi) was 
used to grip the samples (Fig. 4.3) and the cross head speed was fixed at 0.1mm/min.  
  
Figure 4.3 Sample clamped by pneumatic gripper of the Instron 
machine while doing tensile test 
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After sterilization (as described in section 4.1.1.3), all the samples were 
immersed in PBS for up to eight weeks by following the procedure described in 
section 4.1.1.4. At the end of every week, four samples were taken out for testing. To 
avoid drying of the samples, the test was carried out immediately after taking out the 
samples from the solutions. The test was performed at room temperature of 23 ± 2ºC. 
Those samples which broke inside the grip or at the bubble / void (despite taking 
utmost care, voids were present in some of the samples but were not visible from 
outside) were discarded from the test results and replaced by another sample.  
The ultimate tensile strength (UTS) and the breaking strain were determined as 
the maximum stress and strain carried by the sample before breaking. The strength was 
calculated based on the initial cross-sectional area. No external strain gauge was used 
to measure the strain. Elongation was measured from the crosshead movement of the 
gripper and then the strain was calculated dividing the elongation by initial distance of 
the gripper. The modulus of elasticity was determined as the value of slope of the most 
linear region before the maximum stress in the stress – strain curve. (Detailed 
procedure of determining the most linear region and hence to determine the modulus of 
elasticity is illustrated in Appendix E.) 
 
4.1.2.4 Compression Test 
The mechanical compressive properties (i.e. compressive yield strength and 
modulus of compression) and the change of these properties of the molded PLLA with 
time were investigated according to ASTM standard D695. The test was carried out in 
an Instron machine (Fig. 4.4) having a ±1kN load cell. The samples were prepared by 
casting of virgin PLLA (as described in section 4.1.1.2) into the shape of flat strips 
having 2.0mm X 5.0mm cross-section followed by cutting to a length of about 5.0mm 
∼ 7.0mm. The dimensions were chosen in such a way that the slenderness ratio was in 
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the range of 11 to 16:1 as specified by ASTM. After sterilization (as described in the 
section 4.1.1.3), the samples were immersed in PBS for up to eight weeks by following 
the same procedure as described in section 4.1.1.4 and at the end of every week four 
samples were taking out for testing. The samples were placed between the hardened 
parallel block of the machine, and the compressive force applied with the help of those 
parallel blocks at a crosshead speed of 0.1mm/min. The test was conducted at room 
temperature of 23 ± 2ºC. 
 
Figure 4.4 Instron machine for compression test and the enlarged view of the hardened 
parallel block compressing the sample 
 
Subsequently, the compressive strength was determined as the maximum 
compressive stress carried by the test specimen during the test. Similar to the tensile 
test, in this compressive test strength was also calculated based on the initial cross-
sectional area and the modulus of elasticity (compression) was determined as the slope 
value of the most linear region before the maximum stress of the stress – strain curve. 
(Detailed procedure of determining the most linear region and hence to determine the 
modulus of elasticity is illustrated in Appendix E.) 
 





Fabrication of the ring is one of the most critical steps of this project. The 
chosen material PLLA is available in the market only in the form of either powder 
(small pellets) or fiber. To fabricate the ring, a solid 3D shape of this material is 
needed first and to do this, casting of the raw material (in pellet form) is done.   
 
4.2.1 Solvent Casting 
This involves making a solution of the polymer by using suitable solvent, then 
pouring the solution into a mold and finally getting the shape and structure after 
evaporation of the solvent.  
For the solvent casting of PLLA, chloroform is used as a solvent. Then this 
PLLA solution (0.5gm PLLA with 3.3ml chloroform i.e. concentration of PLLA is 
15% w/v) is cast into a simple cylindrical shape mold. Since the chloroform is volatile, 
it has been expected that PLLA would become a solid 3D shape after evaporation of 
chloroform, but unfortunately, in this method PLLA came out as a non-homogenous 
shape after evaporation of the chloroform (Fig. 4.5).  
 
Figure 4.5 PLLA after simple solvent casting 
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It has been observed that chloroform evaporates first from the top surface of the 
solution and therefore a thin layer of PLLA is formed at the upper portion of the 
solution. That thin layer becomes thicker with time and then it acts as a barrier and 
prevents further evaporation of the chloroform. After a certain period of time, that 
upper layer breaks down and the evaporation continues. This results in a non-
homogenous porous structure being formed instead of a solid 3D structure.  
Besides this simple way of evaporation, freeze drying of the PLLA solution 
was also tried to get a solid structure. In this case, PLLA came out in the form of foam. 
Further, the casting was also done at low pressures (200∼300 mm Hg vacuum 
pressure) to facilitate the quick evaporation. Nevertheless, it also failed to make a solid 
structure. The pictures of these castings are shown below (Figs. 4.6 – 4.7).  
   
Figure 4.6 PLLA after solvent casting in 
freeze drying environment 
Figure 4.7 PLLA after solvent casting in 
low Pressure 
 
Higher concentrations of PLLA solution (up to 50% w/v) were also tried, but it 
did not improve, and only made it more difficult to pour the solution into the mold. 
Finally, a conclusion was made that this method of solvent casting cannot be used to 
fabricate the solid 3D structure, although this technique is quite effective for producing 
thin sheets (e.g. thickness less than 1mm).  
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4.2.2 Melted Casting 
Since the PLLA is a kind of thermoset plastic, melting is another promising 
technique to produce solid 3D structure. Auras et al. (2003) [93] first reported the use 
of PLLA for packaging purposes. In their study, they reported that PLLA can be 
formed by sheet extrusion, blow stretch molding, thermoforming and film forming. A 
year later, Altpeter et al. [86] also showed that PLLA can be formed by injection 
molding too. Therefore, it has been also tried to do casting by melting. Finally, a 
homogenous solid 3D structure is obtained by melting the pellet form of raw PLLA at 
190ºC. A picture of this casting is shown below (Fig. 4.8).  
 
Figure 4.8 PLLA after melt casting 
 
Now we attempted to fabricate the ring according to the design shown in 
section 3.5 (Figs. 3.10 – 3.11) by melt casting. The mold was designed accordingly 
(Please refer to Figs. D5 – D8 of Appendix D for mold design). Primarily, aluminum 
was chosen as the mold material because it is easier for machining. At first, one side of 
the ring (male port) was fabricated in this way (Fig.4.9). Dimensional accuracy and the 
surface finish are quite good, but while trying to fabricate the other side of the ring 
(female port), problems were encountered. The ring broke while being taken out from 
the mold although the mold is of the split type (composed of several parts) (Mold 
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design is given in the Appendix D) which is supposed to be easier to release of the 
material.  
  
Figure 4.9 Male port (one part of the ring) made by melt casting, held at 
the tip of a forceps (left); placed on a mm scale (right) 
 
This breakage may be caused by the strong adhesion between the polymer and 
the mold material. So, the mold material was changed to brass, but still resulted in 
breakage of the component. Some release agent (e.g. Silicon\PTFE lubricant that is 
mainly used for plastic molding) was also used to facilitate the easier removal of the 
material from the mold, but that did not improve matters. 
 
4.2.3 Conventional Machining 
Since, PLLA has almost similar characteristics as that of common plastics, 
conventional machining may be another promising technique for fabrication of the 
PLLA ring. Therefore, finally we tried using conventional machining to fabricate the 
ring. At first, we made a cylindrical rod by melting and then machined it to our desired 
shape by using a conventional milling machine. This technique seems to work pretty 
well, and finally, the ring to our desired size and shape was fabricated (Fig. 4.10), 
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except for the poor surface finish. The latter resulted in the two rings not meshing with 
each other properly.  
  
Figure 4.10 Female port (another part of the ring) made by melt casting 
followed by conventional machining, held by hand (left); placed on an 
mm scale (right) (the length is not trimmed to actual size) 
 
Since this polymer is some kind of plastic, so while machining, burr are 
produced on the surface. This may be because of the incorrect cutting speed and 
cutting conditions. Therefore, it should be chosen proper cutting condition and 
lubricant to avoid this. Another thing is note is that since the dimensions of the ring are 
so small (with 1.5mm inner slot), it is not easy to machine with proper alignment and 
high accuracy unless one uses a good machine. 
From the experience, it is quite clear that solvent casting is suitable only to 
fabricate thin sheets (e.g. thickness less than 1.0mm) which may be useful in tissue 
engineering purpose. It is not possible to fabricate a solid 3D structure by this method. 
Therefore, one part of the ring (male port) was fabricated by casting of the melted 
virgin polymer into the final ring shape directly, whereas another part (female port) 





TEST RESULTS AND DISCUSSION 
 
 
The results obtained from testing of the material are discussed in the following 
sections of this chapter. A comprehensive discussion on the results is also incorporated 
at the end of this chapter. 
 
5.1 Test Results  
 
5.1.1 Differential Scanning Calorimetry (DSC) 






















Figure 5.1 DSC thermograms of PLLA before and after casting 
 
The area under the curve measured using the software provided the 





Temperature Zone Secondary 
Crystallization Peak
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(i.e. melting temperature, glass transition temperature and crystallinity) obtained from 
analyzing the above DSC signals are summarized in the following table (Table 5.1).  
 
Table 5.1 Thermal properties of PLLA before and after casting 
 Tg (ºC) Tm (ºC) 
Crystallinity 
(%) 
Before casting 52.55 170.27 9 
After casting 55.04 174.07 28 
 
 
5.1.2 Degradation Test 
The change in weight of the molded PLLA immersed in PBS over eight weeks 
is shown in Table 5.2 and Fig. 5.2, where -ve sign indicates weight loss whereas +ve 
sign indicates weight gain i.e. increases of weight after immersion. The result does not 
show any significant change in the weight of the molded PLLA samples within eight 
weeks. 
 
Table 5.2 Change in weight (%) of molded PLLA immersed in PBS over eight weeks 








5 Average SD 
1 0.16 0.04 0.10 0.12 -0.06 0.07 0.08 
2 0.26 0.26 0.24 0.18 0.04 0.20 0.09 
3 -0.40 -0.04 0.56 -0.54 -0.28 -0.14 0.43 
4 -1.69 0.46 0.30 0.00 0.35 -0.12 0.90 
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5 -1.37 0.50 -1.22 0.52 0.38 -0.24 0.97 
6 -1.39 -0.37 0.00 0.17 0.27 -0.26 0.67 
7 -0.17 0.40 -0.12 -1.41 -0.51 -0.36 0.67 
8 -0.81 -0.49 -0.10 -0.14 -0.40 -0.39 0.29 
 






















Figure 5.2 Change in weight of molded PLLA immersed in PBS over eight weeks 
 
5.1.3 Tensile Test 
The changes in mechanical tensile properties (i.e. ultimate tensile strength, 
breaking strain and modulus of elasticity) of molded PLLA after immersing in PBS 
over the eight weeks are shown in Table 5.3 and Figs. 5.3 – 5.5. Four individual 
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Table 5.3 Tensile properties of molded PLLA immersed in PBS over eight weeks 
 































Figure 5.3 Change in ultimate tensile strength of the molded PLLA immersed in PBS 
over eight weeks 





Week 0 39.96 ± 2.69 3.46 ± 0.33 1273.33 ± 76.33 
Week 1 33.65 ± 2.88 4.04 ± 0.48 1014.10 ± 190.12 
Week 2 26.30 ± 1.53 2.96 ± 0.50 1024.79 ± 197.95 
Week 3 19.37 ± 3.87 1.84 ± 0.38 1074.33 ± 23.72 
Week 4 15.90 ± 1.08 1.64 ± 0.36 1066.9 ± 105.51 
Week 5 13.21 ± 4.87 1.07 ± 0.28 964.92 ± 41.07 
Week 6 14.17 ± 1.85 1.65 ± 0.20 926.77 ± 98.99 
Week 7 8.67 ± 1.91 1.04 ± 0.32 924.29 ± 51.90 
Week 8 7.90 ± 3.85 1.07 ± 0.24 757.23 ± 205.94 
Chapter 5  Test Results and Discussion 
 
66 

























Figure 5.4 Change in breaking strain of the molded PLLA immersed in PBS 
over eight weeks 


























Figure 5.5 Change in modulus of elasticity of the molded PLLA immersed in PBS 
over eight weeks 
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Properties represented at the 0th week indicate the properties just after casting 
of the virgin PLLA. The detailed mechanical test data of individual samples are given 
in Appendix G. Tensile test results show that, the initial ultimate tensile strength (UTS) 
and modulus of elasticity of the molded PLLA are 40MPa and 1.17GPa respectively 
and before breakage it can elongate about 3.46%. The results also show that after eight 
weeks of immersion in PBS, PLLA loses about 80% of its initial strength. The 
elongation at breakage and the tensile modulus reduces about 70% and 35% 
respectively from their initial values. The strength drops almost exponentially, whereas 
no definite relationship can be found for drop of the tensile modulus and the breaking 
strain.  
 
5.1.4 Compression Test 
The changes in compressive properties (i.e. compressive strength and modulus 
of compression) of molded PLLA after immersion in PBS over eight weeks is shown 
in Table 5.4 and Figs 5.6 – 5.7. Four individual specimens are tested in every week. 
Table 5.4 Compressive properties of molded PLLA immersed in PBS over eight weeks 
 Compressive  Strength (MPa) 
Modulus of 
Compression (MPa) 
Week 0 95.28 ± 5.50 1293.73 ± 180.82 
Week 1 85.18 ± 5.26 1182.19 ± 222.96 
Week 2 66.16 ± 9.43 954.05 ± 178.31 
Week 3 51.74 ± 2.82 683.39 ± 48.23 
Week 4 49.14 ± 3.36 657.29 ± 61.91 
Week 5 43.75 ± 3.27 519.72 ± 39.99 
Week 6 41.38 ± 6.46 495.71 ± 35.38 
Week 7 39.20 ± 4.83 554.38 ± 116.79 
Week 8 23.71 ± 4.83 356.2 ± 116.79 





























Figure 5.6 Change in compressive strength of the molded PLLA immersed in PBS 
over eight weeks 
 


























Figure 5.7 Change in modulus of compression of the molded PLLA immersed in PBS 
over eight weeks 
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Properties represented at 0th week indicate those just after casting of the virgin 
PLLA. The details of the compression test data of the individual samples are given in 
Appendix H. Compression test results show that the initial compressive strength and 
modulus of elasticity for compression of the molded PLLA are 95MPa and 1.3GPa 
respectively. The results also show that within eight weeks of immersion in PBS, 
PLLA loses about 58% of its initial strength and the strength drops almost 
exponentially. The modulus of elasticity for compression also drops by about 57%.  
 
5.2 Discussion 
The DSC thermograms (Fig. 5.1) show that the % of crystallinity has been 
increased from 9% to 28% due to casting, which indicates that the casting procedure 
has changed the inter-molecular structure of the polymer and consequently its 
crystallinity, molecular weight etc. During casting, the virgin PLLA was heated to 
190ºC, although the DSC shows that the melt temperature of virgin polymer is 170ºC. 
We relied on gravitational force to flow the liquid polymer over the mold, but the 
liquid polymer at 170ºC was found to be too viscous to flow. Consequently, we had to 
heat the polymer to a higher temperature to facilitate the flowing of the liquid PLLA. 
Moreover, this whole process (melting of the solid polymer and pouring of the liquid 
polymer into the mold cavity) needs a considerable time. Therefore, these factors are 
responsible for this change in polymer inter-molecular structure.  
Both crystallinity and molecular weight are important factors in the case of 
polymeric implants, because they influence the physical and mechanical properties as 
well as degradation kinetics of the polymer. However, it is well known that PLLA is 
highly sensitive to temperature as well as the processing technique. Literature shows 
that depending upon processing technique and temperature PLLA may lose even 90% 
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of its initial molecular weight [88]. Beside this, it has been also found that highly 
crystallized bone fixatives had induced inflammation [94]. So, the % of crystallinity 
should not be increased. Therefore, to reduce thermal degradation, the heating time 
(i.e. the processing time) as well as heating temperature should be kept as low as 
possible. In that case, alternative way of casting e.g. injection molding or compression 
molding that is quite effective and popular for plastic molding, can be considered. 
These techniques are very fast and use higher pressures to flow the liquid to fill up the 
mold cavity; hence heating of the polymer to a higher temperature and for a prolonged 
time can be avoided. Thereby, thermal degradation or loss of molecular weight also 
can be kept to a minimum level. 
The study shows that initial tensile strength (σT) and modulus of elasticity (ET) 
of the molded PLLA is 40MPa and 1.27GPa, compressive strength (σC) and modulus 
of compression (EC) is 95MPa and 1.29GPa respectively. A wide range of these values 
can be found in the literature. As for example, Leenslag et al. [81] reported, for as 
polymerized PLLA plates σT = 75MPa and ET = 5GPa whereas for compression 
molded PLLA plates these values are 83Mpa and 4GPa respectively. In another study, 
Auras et al. [93] showed as polymerized PLLA film has σT = 65 ~ 84MPa and ET = 
2.11 ~ 2.87GPa.  
However, it is well known that mechanical properties of resulting PLLA 
structure depends upon its molecular weight [85], % of crystallinity [95], purity [96] 
etc.; which in turns also depends upon the processing or fabrication technique of that 
structure as well as the grade of the initial polymer too. Literature also proves that, 
mechanical properties of PLLA can be greatly altered by controlling the process 
parameters e.g. for molding mold temperature or injecting pressure, for drawing draw-
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ratio or speed etc. [86 – 90]. Therefore, these values can not be strictly compared with 
others.  
The study shows that there is no significant change in weight of molded PLLA 
over the eight weeks; although within these eight weeks PLLA exhibited a massive 
loss in tensile strength (σT) from 40MPa to 8MPa (80%) and also in compressive 
strength (σC) from 95MPa to 24MPa (75%) and the strength drops almost 
exponentially. Modulus of elasticity (ET) and modulus of compression (EC) also drops, 
but there is no definite relationship with the time.  
Literature also shows the similar results of no weight loss at initial stage of 
degradation although continuous drop in mechanical strength. But, a wide variation in 
the rate of losing strength can be found within these literatures. As for example, 
Leenslag et al. [97] reported a massive loss in strength of about 80% within eight 
weeks and about 95% within 12 weeks; whereas they could detect only 5% weight loss 
at the end of 39 weeks.  
However, the degradation kinetics (rate of losing strength or mass) reported by 
Leenslag et al. is much similar to the result obtained in this study. On the other hand, 
Nuutinen et al. [98] reported much slower rate of degradation as compare to these 
studies. In their follow up of 104 weeks of braided PLLA stents immersed in PBS, 
PLLA loses only 40% of its initial tensile strength within eight weeks and almost 
100% within 35 weeks; whereas for mass loss they got no change of mass for the first 
26 weeks and still had 60% mass left at the end of 104 weeks. 
In another long term study, Pistner et al. [99] reported that crystalline PLLA 
loses 80% of its initial strength (bending strength) within eight weeks and almost 
100% within 25 weeks, whereas amorphous PLLA loses only 10% within eight weeks, 
50% within 16 weeks and almost 100% within 32 weeks. They have also reported that 
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for crystalline PLLA they could detect a significant weight loss only after 5 weeks 
whereas for amorphous PLLA it is about 40 weeks and once started to lose weight the 
amorphous PLLA degrades faster than the crystalline PLLA. As a result, at the end of 
the 72 weeks they found crystalline PLLA left 85% of their initial mass whereas 
amorphous PLLA left only 80%. However, this difference in degradation rate is 
attributed to their difference in microstructure. The amorphous sample (prepared by 
injection molding) used in their study had a more sealed surface and tight internal 
structure; whereas as polymerized crystalline samples had micro-porous structure. 
Finally, in another report the author proves that the degradation kinetics of PLLA (both 
of mass and mechanical strength) depends not only upon the initial molecular weight 
of the polymer, but also upon the internal structure (micro-porous, tight surface) and 
different solid states (amorphous, crystalline i.e. % of crystallinity) of the polymer 
[100].  
To understand the behavior of strength loss without significant mass loss for 
molded PLLA, it is necessary to look at the degradation mechanism. It is widely 
accepted that PLLA is degraded by simple hydrolysis. However, there is also a general 
consensus that this hydrolysis proceeds in two distinct stages [101]. The first stage is 
characterized by the preferential attack of the ester linkage in the more accessible 
amorphous regions [102], with the second stage characterized by the onset of mass loss 
and attack of the less accessible crystalline regions [103 – 104].  
Therefore, when a semi-crystalline PLLA structure is subjected to an aquas 
medium, the amorphous portion starts degrade first through random scission of its ester 
bonds along the polymer chain leaving back the crystalline domains of the polymer 
[100]; which leads to uniform decay of molecular weight [97 – 100] as well as 
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increasing the overall crystallinity of the polymer [97,100]. Since there is continuous 
break up of the molecular chain, obviously the strength would also drop continuously.  
However, in conjunction with the two-stage degradation mechanism, Li et al. 
[105 – 106], examining the degradation of PLLA, proved that degradation occurs more 
rapidly in the center than at the surface, which is known as heterogeneous degradation 
or bulk degradation and is widely accepted as occurring in both lactide and glycolide 
polymers [107].  This heterogeneous degradation results from the hydrolytic cleavage 
of the ester bonds forming new acidic carboxyl end groups. As degradation proceeds 
the soluble oligomers produced close to the surface can escape, while those in the 
center can not diffuse out of the polymer. It decreases the pH (i.e. increases the acidity) 
of the bulk polymer; which leads to autocatalysis and further drop in pH resulting a 
differentiation between the surface and interior degradation rate [108]. This auto-
catalyzing effect also causes a rapid loss of strength of the polymer.  
The time delay before observing any significant mass loss is a general sequence 
of aliphatic polyester degradation. This is due to the fact that water diffusion is faster 
than the hydrolytic degradation of the polymer’s ester linkage, suggesting that ester-
bond cleavage is the rate-limiting step in the degradation of aliphatic polyesters [109]. 
Since the degradation proceeds in the bulk of the polymer, so it needs certain time to 
reduce the polymer’s molecular weight to a critical value before soluble oligomers can 
diffuse out of the polymer [108]. Consequently, it causes a considerable time lag to 
onset of the mass loss, although strength would be losing due to continuous breaking 
of the ester bond through hydrolysis; which has been also found at this study. 
PLLA used in this study had a very low % of crystallinity (28%) which 
indicates that the proportion of the amorphous region is much higher than that of the 
crystalline. Literature suggests that water can intrude easily into the amorphous 
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domains as compared to the crystalline domains of the polymer [100]. Moreover, the 
amorphous region is more open as compared to the closely packed crystalline region 
[102], which allows more water molecules to penetrate into the amorphous regions. 
Therefore, it causes a rapid loss of strength. Moreover, examining on PLGA Loo et al. 
[110] proves that increasing the crystallinity due to annealing (heating to a temperature 
over glass transition temperature) of a semicrystalline polymer results in an even more 
open amorphous region and formation of voids which in turns increases the rate of 
degradation. The samples used in this study undergo a prolonged heating while 
preparing by casting; which also increased the crystallinity of this PLLA. Therefore, it 
can be also said that this increase in crystallinity (due to prolonged heating) also results 
a more open amorphous region and formation of voids. Consequently, it causes further 
increasing in the rate of degradation that results a massive loss of strength within eight 
weeks. 
However, this rate of hydrolysis and consequently the time delay to onset the 
mass loss as well as the rate of degradation (i.e. the rate of losing strength and mass) is 
governed by the concentration of carboxylic end groups and the diffusion of fluid 
which in turns depends upon the internal structure of the polymer. Therefore, it is a 
common agreement that the degradation rate of PLLA and aliphatic polyesters in 
general, is strongly related to their material properties with microstructure, 
crystallinity, molecular weight and distribution, orientation, un-reacted monomer and 
the presence of impurities [111], although no exact values or no exact correlation has 








The growing interest in minimally invasive approaches in vascular surgery and 
other surgical specialties has led the researchers to look for alternative, feasible 
methods of creating a vascular anastomosis. The aim is to achieve it without 
compromising quality or patency rates, and with at least the same results or better than 
those obtained by standard suturing techniques. If less manipulation and trauma to the 
vascular wall is obtained with any of these alternative methods, it is possible to have 
better clinical results, especially in microvascular anastomoses. Therefore, a new 
device has been developed for microvascular anastomosis that consists of an 
absorbable ring with an interlocking mechanism and to attach the blood vessel to the 
ring with glue. The device needs less manipulation of the vessel. According to this 
technique only one piercing of vessel is necessary to attach it with a ring, and hence it 
is expected that this technique would cause less vessel trauma. Moreover, no material 
is placed inside the lumen. So theoretically, there is a less risk of vascular thrombus 
formation. The entire anastomosis can be completed within 10 min by using this 
device whereas it takes about 20 min by suturing technique. Therefore, it is expected 
that anastomotic time can be reduced to a great extent with this new device; which was 
the main objective of this study for developing a new anastomosis device. 
Furthermore, since the vessel is attached to the ring with the help of glue, this 
technique can accommodate a little vessel size discrepancy.  
On the other hand, this device has some limitations too. Firstly, it is not capable 
of performing end-to-side anastomosis. Moreover, since this technique is capable of 
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accommodating only a limited vessel size discrepancy, it needs various sizes of rings 
to be prepared before the operation.  
Regarding the fabrication of the ring, it is not possible to fabricate the ring by 
solvent casting; the only way is to cast the polymer after melting it. Once the solid 3D 
structure is obtained by casting, machining is done to fabricate the ring. However, in 
fact, in terms of safety, machining may not be suitable for fabricating such a small 
medical device. The main reason is it may introduce some germs while using coolant 
for machining. Moreover, it is not so easy to clamp such a small piece of material for 
machining. That is why emphasis should be on fabrication by direct casting (after 
melting) method. However, the most critical part of direct casting is the releasing of 
the molded pieces from the mold cavity without breakage. Therefore, keeping in mind 
the difficulties associated with this direct casting, we would like to recommend 
checking the following possibilities to fabricate the ring with better quality as well as 
with better dimensional accuracy:   
 Selecting proper mold material having low adhesion coefficient with the 
ring material e.g. silicon or stainless steel. Many plastic product 
manufacturers use molds of these materials. Since PLLA is also a kind of 
plastic, any of these materials can be selected. 
 Selecting proper release agent to facilitate releasing of the material from the 
mold, but care should be taken to ensure that the release agent does not 
have any reactivity with the polymer at its melting temperature.  
 Modifying the mold design i.e. splitting the mold into more number of 
pieces. 
 Consider some other advanced technologies for molding e.g. sacrificial 
molding system.  
Chapter 6   Conclusion & Recommendation 
 
77 
 To reduce thermal degradation of the polymer, keeping the processing time 
(heating and pouring the liquid into the mold cavity) to a minimum and 
therefore high pressure (like injection molding) should be used to flow the 
liquid into the mold cavity. 
Surely the dimensions shown here do not represent the optimum size of the 
ring. However, in future, a finite element model should be developed based on the 
material testing results to find out the optimum size, provided the test samples must be 
prepared in a way similar to the fabrication of the ring. Since the properties of this kind 
of polymer is greatly influenced by the processing technique, it is necessary to prepare 
the sample and ring in the same way and both of it should also undergo the same 
sterilization technique so that the sample can represent the polymer morphology of the 
ring.  
According to the proposed technique, the ring acts as a supporting structure 
until natural healing of the vessel ends occur, and hence after healing, there is no 
necessity for the ring to stay. Usually, it needs about 2 to 3 months for complete 
healing of the blood vessel. Therefore, the ring should start degrading within this 
period of time and should be fully dissolved as early as possible after natural healing of 
the blood vessel. However, from the experiments, PLLA does not show any sign of 
degradation within eight weeks in PBS; which means the degradation rate is much 
slower than needed. Therefore, the ring material should be reconsidered. In that case, 
using the co-polymer of PLA and PGA (PLGA) may be considered. Since both of 
these materials are under the same group, it can be expected that PLGA would also be 
able to undergo the similar forming method (i.e. casting and machining) that was used 
for PLLA. But since PGA is weaker than PLA, the ring would lose its strength too. 
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Therefore, it is necessary to find the optimum ratio for PLA and PGA to match the 
combination of required strength and degradation rate.  
From the testing of the ring model, it may seem that the proposed method is quite 
satisfactory, but since glue plays an important role in this technique, and glue 
properties (e.g. the bonding strength) largely depend upon the surface property of the 
mating components, it is not possible to predict with certainty what will happen in case 
of an actual anastomosis. Moreover, blood vessels are very soft, thin and easily 
collapsible. Therefore, in future after fabricating the ring the efficacy of this technique 
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Table: Thermal and mechanical properties of common biodegradable polymers (the summery of a comparative study reported by Engelberg et 
al. [83])  
                                                 
† Absolute weight average molecular weights as provided by the supplier of the polymer 
‡ Viscosimetric molecular weight   








at yield  (%) 
Elongation 
at break (%) 
Poly (glycolic acid) 
(PGA) 50 000 - 35 210 52 N/A N/A N/A N/A 
Poly (lactic acid) 
(PLA)          
L-PLA 50 000 19 600 54 170 30 28 1200 3.7 6.0 
L-PLA 100 000 43 200 58 159 15 50 2700 2.6 3.3 
L-PLA 300 000 150 000 59 178 29 48 3000 1.8 2.0 
D,L-PLA 21 000 13 400 50 - - N/A N/A N/A  
D,L-PLA 107 000 66 300 51 - - 29 1900 4.0 6.0 
D,L-PLA 550 000 163 500 53 - - 35 2400 3.5 5.0 
Poly (ε-caprolactone) 
(PCL) 44 000 42 500 -62 57 - 16 400 7.0 80 
APPENDIX A 
THERMAL & MECHANICAL PROPERTIES OF BIODEGRADABLE POLYMER 
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BIOGLUE COMPONENTS 
Bovine Serum Albumin (45% w/v) + 
Glutaraldehyde (10% w/v) = BioGlue 
 
 
REACTION MECHANISM  
BioGlue is based on the reaction of amines 
with aldehydes.  Glutaraldehyde binds 
the albumin molecules to each other and 
to the cell surface proteins and 
extracellular matrix (ECM) proteins.  The 
many binding sites on albumin provide an 
extensive network of bonds, resulting in a 
strong but flexible implant.  This reaction 
is spontaneous and independent of the 
coagulopathic state of the patient. 
BOVINE SERUM ALBUMIN (BSA)
PURIFICATION METHODOLOGY
The bovine serum used as the source 
 
of albumin in BioGlue comes from U.S. 
& Canadian cattle only.  There are three 
major steps in the bovine serum albumin 
purification process (two heat precipita- 
tions and one chromatography).  Initially, 
the bovine plasma is heat fractionated 
which precipitates unwanted proteins and 
potentially infective agents out of solution,
leaving purified albumin behind. After 
undergoing this process twice, 
the solution is further purified using 
chromatographic resins to bind up any 
impurities. Studies have demonstrated 
that these processing steps are effective 
against viruses and Transmissible 
Spongiform Encephalopathy (TSE)1.
 
























Appendix C  Technical Specification of BioGlue 
 
C-2 
 B      I      O      G      L      U      E            S     U     R     G     I     C     A     L A     D      H      E      S      I     V     E
B IOGLUE —  IN VIVO  
The two components are mixed at a 4 (BSA) to 1 (Glutaraldehyde) ratio in the applicator tip. The polymeriza- 
tion process begins immediately and the two components are consumed as the aldehydes and the lysine side 
chains of BSA are linked together. Only enough glutaraldehyde remains to bind the BSA to the target site. 
BioGlue is a protein based hydrogel, which has been shown to resorb in the body. The resorption process is 








(Fig. 1) (Fig. 2)
The body elicits a minimal foreign body response 
at the target site. (Figure 1, H&E stained, 7 day 
implant showing repair of aortic dissection). 
After 1 year, the implant is intact  (Figure 2, H&E














(Fig. 3a) (Fig. 3b)
After 2 years, localized degradation is observed.
(Figure 3a, H&E stained, showing anastomosis of 
aorta to dacron graft). 
As BioGlue is resorbed, it is replaced with normal 
tissue.  (Figure 3b, immuno-stained for collagen 
Type-I, showing anastomosis of aorta to dacron 
graft). 
1 Blum et al., A Bovine Spongiform Encephalopathy Validation Study 
for Aprotinin and Bovine Serum Albumin, BioPharm, 11(4): 28-34, 
1998 
 





Hampshire, PO16 8XT 
United Kingdom 
44 (0) 1329 229800  Phone 













Figure D1 The ring (first proposed design) 
 
Figure D2 The bar lock (first proposed design) 
APPENDIX D 
TECHNICAL DRAWINGS 









Figure D4 Female port (another part of the ring set) 
 




Figure D5 Mold for casting male port (Part A) 
 
 
Figure D6 Mold for Casting Male Port (Part B) 
 




Figure D7 Mold for casting female port (Part A) 
 
 
Figure D8 Mold for casting female port (Part B) 
 




PROCEDURE FOR FINDING MODULUS OF ELASTICITY 
 
To find the Modulus of Elasticity, the crucial part is to find out the most linear (and 
hence representative) region of the stress vs strain curve up to the maximum peak. It 
needs a series of steps which can be briefly summarized as follows.  
Step 1: Identify the maximum stress in stress vs strain curve and then calculate the 
gradient change up to that maximum stress according to the following way. 
Let us consider three point A, B and C on a stress-strain curve (Fig. B1) and 1g  as the 
gradient of AB, and 2g as the gradient of BC, 
 

















Theoretically, this % gradient change of these ABC will be zero if these three points 















Appendix E Procedure for finding Modulus of Elasticity 
 
E-2 
Step 2: Plot the % gradient change with strain. Typically the graph will look like the 
























Figure E2 A typical graph of % gradient change vs strain 
Step 3: From the graph of % gradient change vs strain, it is easy to spot the region of 
the smallest fluctuation of %gradient change which eventually represents the best 
linear portion of the stress-strain curve. Usually, more than 1 region can be identified 
as best linear region. To choose the better one among them, the square of correlation 
factor R2 was calculated and the region giving the higher value of R2 would be 
accepted as the best representative linear region of the stress-strain curve. Even if only 
one potential region was found then R2 value of 0.998 and above would be ensured.  
Step 4: Finally the slope of that representative straight line (for a particular stress-
strain curve of a sample) is taken as the value for modulus of elasticity of that sample. 
Smallest fluctuation region & 
hence represent the most linear 
region of the stress-strain curve 
























































































































































































































Tensile Test Results [Week 0] 
Tensile Stress [MPa] vs Strain [%]
Sample 0_1




















Tensile Stress [MPa] vs Strain [%]
Sample 0_2



























Tensile Stress [MPa] vs Strain [%]
Sample 0_3




















Tensile Stress [MPa] vs Strain [%]
Sample 0_4





















Appendix G   Tensile Test Results 
 
G-3 
Tensile Test Results [Week 1] 
Stress [MPa] vs Strain [%]
Sample 1_1



















Stress [MPa] vs Strain [%]
Sample 1_2

























Stress [MPa] vs Strain [%]
Sample 1_3



















Stress [MPa] vs Strain [%]
Sample 1_4



















Appendix G   Tensile Test Results 
 
G-5 
Tensile Test Results [Week 2] 
Stress [MPa] vs Strain [%]
(Sample 2_1)

















Stress [MPa] vs Strain [%]
(Sample 2_2)
























Stress [MPa] vs Strain [%]
(Sample 2_3)


















Stress [MPa] vs Strain [%]
(Sample 2_4)


















Appendix G   Tensile Test Results 
 
G-7 
Tensile Test Results [Week 3] 
Stress [MPa] vs Strain [%]
(Sample 3_1)



















Stress [MPa] vs Strain [%]
(Sample 3_2)
























Stress [MPa] vs Strain [%]
(Sample 3_3)
















Stress [MPa] vs Strain [%]
(Sample 3_4)

















Appendix G   Tensile Test Results 
 
G-9 
Tensile Test Results [Week 4] 
Stress [MPa] vs Strain [%]
(Sample 4_1)




















Stress [MPa] vs Strain [%]
(Sample 4_2)



























Stress [MPa] vs Strain [%]
(Sample 4_3)



















Stress [MPa] vs Strain [%]
(Sample 4_4)





















Appendix G   Tensile Test Results 
 
G-11 
Tensile Test Results [Week 5] 
Stress [MPa] vs Strain [%]
(Sample 5_1)

















Stress [MPa] vs Strain [%]
(Sample 5_2)




























Stress [MPa] vs Strain [%]
(Sample 5_3)




















Stress [MPa] vs Strain [%]
(Sample 5_4)





















Appendix G   Tensile Test Results 
 
G-13 
Tensile Test Results [Week 6] 
Stress [MPa] vs Strain [%]
(Sample 6_1)


















Stress [MPa] vs Strain [%]
(Sample 6_2)

























Stress [MPa] vs Strain [%]
(Sample 6_3)




















Stress [MPa] vs Strain [%]
(Sample 6_4)




















Appendix G   Tensile Test Results 
 
G-15 
Tensile Test Results [Week 7] 
Stress [MPa] vs Strain [%]
(Sample 7_1)





















Stress [MPa] vs Strain [%]
(Sample 7_2)

























Stress [MPa] vs Strain [%]
(Sample 7_3)

















Stress [MPa] vs Strain [%]
(Sample 7_4)





















Appendix G   Tensile Test Results 
 
G-17 
Tensile Test Results [Week 8] 
Stress [MPa] vs Strain [%]
(Sample 8_1)




















Stress [MPa] vs Strain [%]
(Sample 8_2)

























Stress [MPa] vs Strain [%]
(Sample 8_3)





















♀Note: In the last week (8th week) the samples were so week and were slacked down, so 
while loading to the tensile tester all extra samples (those kept as a factor of safety to 
replace the specimen in the case of breakage inside the grip or breakage at bubble) were 
broken up, therefore there is a shortage of the 4th sample in this 8th week. 
 
The values obtained by analyzing the Strain-Strain curves of these tensile tests are 
summarized in the following tables. 
Appendix G   Tensile Test Results 
 
G-19 
Tensile Test Week 0 
 






4 Average SD 
Ultimate Tensile 
Strength (MPa) 38.89 43.98 38.39 38.58 39.96 2.69 
Breaking Strain 
(%) 2.97 3.63 3.69 3.56 3.46 0.33 
Modulus of 
Elasticity (MPa) 1343.9 1240.8 1327.5 1181.1 1273.3 76.3 
 
Tensile Test Week 1 
 






4 Average SD 
Ultimate Tensile 
Strength (MPa) 37.61 31.69 33.93 31.36 33.65 2.88 
Breaking Strain 
(%) 4.26 3.41 4.52 3.98 4.04 0.48 
Modulus of 
Elasticity (MPa) 1228.8 1068.4 771.9 987.3 1014.1 190.1 
 
Tensile Test Week 2 
 






4 Average SD 
Ultimate Tensile 
Strength (MPa) 26.72 24.11 26.67 27.68 26.30 1.53 
Breaking Strain 
(%) 3.15 2.26 3.44 2.97 2.96 0.50 
Modulus of 
Elasticity (MPa) 806.5 1233.5 915.0 1144.2 1024.8 197.9 
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G-20 
Tensile Test Week 3 
 






4 Average SD 
Ultimate Tensile 
Strength (MPa) 14.41 23.85 19.34 19.87 19.37 3.87 
Breaking Strain 
(%) 1.31 2.20 1.88 1.97 1.84 0.38 
Modulus of 
Elasticity (MPa) 1098.9 1088.8 1062.3 1047.3 1074.3 23.7 
 
Tensile Test Week 4 
 






4 Average SD 
Ultimate Tensile 
Strength (MPa) 16.04 16.59 14.33 16.63 15.90 1.08 
Breaking Strain 
(%) 1.94 1.95 1.23 1.46 1.64 0.36 
Modulus of 
Elasticity (MPa) 941.0 1019.4 1164.6 1142.7 1066.9 105.5 
 
Tensile Test Week 5 
 






4 Average SD 
Ultimate Tensile 
Strength (MPa) 10.24 18.80 8.20 15.62 13.21 4.87 
Breaking Strain 
(%) 1.01 1.01 0.79 1.46 1.07 0.28 
Modulus of 
Elasticity (MPa) 995.5 914.1 1000.9 949.1 964.9 41.1 
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G-21 
Tensile Test Week 6 
 






4 Average SD 
Ultimate Tensile 
Strength (MPa) 13.25 12.22 16.48 14.72 14.17 1.85 
Breaking Strain 
(%) 1.45 1.57 1.67 1.92 1.65 0.20 
Modulus of 
Elasticity (MPa) 930.5 864.5 1065.1 847.0 926.8 99.0 
 
Tensile Test Week 7 
 






4 Average SD 
Ultimate Tensile 
Strength (MPa) 8.79 6.37 11.04 8.47 8.67 1.91 
Breaking Strain 
(%) 0.95 0.72 1.48 1.01 1.04 0.32 
Modulus of 
Elasticity (MPa) 923.0 973.0 948.4 852.7 924.3 51.9 
 
Tensile Test Week 8 
 






4 Average SD 
Ultimate Tensile 
Strength (MPa) 7.87 11.77 4.06  7.90 3.85 
Breaking Strain 
(%) 0.93 1.35 0.93  1.07 0.24 
Modulus of 
Elasticity (MPa) 942.0 794.5 535.2  757.2 205.9 
 




Compression Test Results [Week 0] 
Compressive Stress [MPa] vs Strain [%]
Sample 0_1
























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 0_2






























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 0_3
























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 0_4
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H-3 
Compression Test Results [Week 1] 
Compressive Stress [MPa] vs Compressive Strain [%]
Sample 1_1























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 1_2



































Compressive Stress [MPa] vs Compressive Strain [%]
Sample 1_3




























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 1_4
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H-5 
Compression Test Results [Week 2] 
Compressive Stress [MPa] vs Compressive Strain [%]
Sample 2_1


























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 2_2






























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 2_3


























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 2_4
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H-7 
Compression Test Results [Week 3] 
Compressive Stress [MPa] vs Compressive Strain [%]
Sample 3_1
























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 3_2






























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 3_3

























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 3_4
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H-9 
Compression Test Results [Week 4] 
Compressive Stress [MPa] vs Compressive Strain [%]
Sample 4_1
























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 4_2





























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 4_3

























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 4_4
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H-11 
Compression Test Results [Week 5] 
Compressive Stress [MPa] vs Compressive Strain [%]
Sample 5_1




























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 5_2





























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 5_3



























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 5_4
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H-13 
Compression Test Results [Week 6] 
Compressive Stress [MPa] vs Compressive Strain [%]
Sample 6_1


























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 6_2






























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 6_3




























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 6_4
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H-15 
Compression Test Results [Week 7] 
Compressive Stress [MPa] vs Compressive Strain [%]
Sample 7_1




























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 7_2
































Compressive Stress [MPa] vs Compressive Strain [%]
Sample 7_3




























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 7_4
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H-17 
Compression Test Results [Week 8] 
Compressive Stress [MPa] vs Compressive Strain [%]
Sample 8_1

























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 8_2






























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 8_3
























Compressive Stress [MPa] vs Compressive Strain [%]
Sample 8_4
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H-19 
The values obtained by analyzing the Strain-Strain curves of these compression tests are 
summarized below. 
 
Compression Test Week 0 
 






4 Average SD 
Compressive  
Strength (MPa) 94.90 96.61 88.16 101.46 95.28 5.50 
Modulus of 
Compression (MPa) 1047.9 1367.9 1286.2 1472.9 1293.7 180.8 
 
 
Compression Test Week 1 
 






4 Average SD 
Compressive  
Strength (MPa) 83.68 78.68 91.00 87.34 85.18 5.26 
Modulus of 
Compression (MPa) 978.3 1069.5 1190.8 1490.1 1182.2 223.0 
 
 
Compression Test Week 2 
 






4 Average SD 
Compressive  
Strength (MPa) 73.01 54.82 74.78 62.02 66.16 9.43 
Modulus of 











Compression Test Week 3 
 






4 Average SD 
Compressive  
Strength (MPa) 52.24 49.84 55.52 49.35 51.74 2.82 
Modulus of 
Compression (MPa) 678.6 667.8 750.6 636.6 683.4 48.2 
 
 
Compression Test Week 4 
 






4 Average SD 
Compressive  
Strength (MPa) 48.03 46.74 54.12 47.68 49.14 3.36 
Modulus of 
Compression (MPa) 600.9 712.5 709.2 606.5 657.3 61.9 
 
 
Compression Test Week 5 
 






4 Average SD 
Compressive  
Strength (MPa) 41.34 46.20 40.54 46.91 43.75 3.27 
Modulus of 
Compression (MPa) 495.5 528.6 572.2 482.6 519.7 40.0 
 
 
Compression Test Week 6 
 






4 Average SD 
Compressive  
Strength (MPa) 34.40 49.14 43.81 38.15 41.38 6.46 
Modulus of 
Compression (MPa) 547.9 478.0 470.6 486.2 495.7 35.4 






Compression Test Week 7 
 






4 Average SD 
Compressive  
Strength (MPa) 41.52 31.99 41.05 42.25 39.20 4.83 
Modulus of 
Compression (MPa) 583.5 399.3 553.8 680.9 554.4 116.8 
 
 
Compression Test Week 8 
 






4 Average SD 
Compressive  
Strength (MPa) 26.03 24.16 23.39 21.26 23.71 1.98 
Modulus of 
Compression (MPa) 346.1 376.8 385.3 316.5 356.2 31.4 
 
